

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Premature ejaculation: challenging new and the... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-2084/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-2084" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Premature ejaculation: challenging new and the old concepts" />
    
            <meta name="og:title" content="F1000Research Article: Premature ejaculation: challenging new and the old concepts.">
            <meta name="og:description" content="Read the latest article version by Odunayo Kalejaiye, Khaled Almekaty, Gideon Blecher, Suks Minhas, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="13152">
            <meta name="article-id" content="12150">
            <meta name="dc.title" content="Premature ejaculation: challenging new and the old concepts">
            <meta name="dc.description" content="Premature ejaculation remains a difficult condition to manage for patients, their partners, and the clinician. Whilst prevalence rates are estimated to be 20&ndash;40%, determining a diagnosis of premature ejaculation is difficult, as the definition remains both subjective and ill-defined in the clinical context. As our understanding of the ejaculatory pathway has improved, new opportunities to treat the condition have evolved with mixed results. In this review, we explore some of these controversies surrounding the aetiology, diagnosis, and treatment of this condition and discuss potential novel therapeutic options.">
            <meta name="dc.subject" content="Premature ejaculation, Treatment, Aetiology, Diagnosis, Physiology">
            <meta name="dc.creator" content="Kalejaiye, Odunayo">
            <meta name="dc.creator" content="Almekaty, Khaled">
            <meta name="dc.creator" content="Blecher, Gideon">
            <meta name="dc.creator" content="Minhas, Suks">
            <meta name="dc.date" content="2017/12/04">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.12150.1">
            <meta name="dc.source" content="F1000Research 2017 6:2084">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Premature ejaculation">
            <meta name="prism.keyword" content="Treatment">
            <meta name="prism.keyword" content="Aetiology">
            <meta name="prism.keyword" content="Diagnosis">
            <meta name="prism.keyword" content="Physiology">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/12/04">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="2084">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.12150.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-2084">
            <meta name="citation_title" content="Premature ejaculation: challenging new and the old concepts">
            <meta name="citation_abstract" content="Premature ejaculation remains a difficult condition to manage for patients, their partners, and the clinician. Whilst prevalence rates are estimated to be 20&ndash;40%, determining a diagnosis of premature ejaculation is difficult, as the definition remains both subjective and ill-defined in the clinical context. As our understanding of the ejaculatory pathway has improved, new opportunities to treat the condition have evolved with mixed results. In this review, we explore some of these controversies surrounding the aetiology, diagnosis, and treatment of this condition and discuss potential novel therapeutic options.">
            <meta name="citation_description" content="Premature ejaculation remains a difficult condition to manage for patients, their partners, and the clinician. Whilst prevalence rates are estimated to be 20&ndash;40%, determining a diagnosis of premature ejaculation is difficult, as the definition remains both subjective and ill-defined in the clinical context. As our understanding of the ejaculatory pathway has improved, new opportunities to treat the condition have evolved with mixed results. In this review, we explore some of these controversies surrounding the aetiology, diagnosis, and treatment of this condition and discuss potential novel therapeutic options.">
            <meta name="citation_keywords" content="Premature ejaculation, Treatment, Aetiology, Diagnosis, Physiology">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Odunayo Kalejaiye">
            <meta name="citation_author_institution" content="Department of Andrology, University College London Medical School, London, W1G 8PH, UK">
            <meta name="citation_author" content="Khaled Almekaty">
            <meta name="citation_author_institution" content="Department of Andrology, University College London Medical School, London, W1G 8PH, UK">
            <meta name="citation_author_institution" content="Urology Department, University of Tanta, Tanta, Egypt">
            <meta name="citation_author" content="Gideon Blecher">
            <meta name="citation_author_institution" content="Department of Andrology, University College London Medical School, London, W1G 8PH, UK">
            <meta name="citation_author" content="Suks Minhas">
            <meta name="citation_author_institution" content="Department of Andrology, University College London Medical School, London, W1G 8PH, UK">
            <meta name="citation_publication_date" content="2017/12/04">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="2084">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.12150.1">
            <meta name="citation_firstpage" content="2084">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-2084/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-2084.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=13152 /> <input type=hidden id=articleId name=articleId value=12150 /> <input type=hidden id=xmlUrl value="/articles/6-2084/v1/xml"/> <input type=hidden id=xmlFileName value="-6-2084-v1.xml"> <input type=hidden id=article_uuid value=aaad83d5-9adf-4666-8d6e-14d5c966dd0a /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Premature ejaculation: challenging new and the old concepts"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.12150.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.12150.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-2084"
  },
  "headline": "Premature ejaculation: challenging new and the old concepts",
  "datePublished": "2017-12-04T10:31:54",
  "dateModified": "2017-12-04T10:31:54",
  "author": [
    {
      "@type": "Person",
      "name": "Odunayo Kalejaiye"
    },    {
      "@type": "Person",
      "name": "Khaled Almekaty"
    },    {
      "@type": "Person",
      "name": "Gideon Blecher"
    },    {
      "@type": "Person",
      "name": "Suks Minhas"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Premature ejaculation remains a difficult condition to manage for patients, their partners, and the clinician. Whilst prevalence rates are estimated to be 20&ndash;40%, determining a diagnosis of premature ejaculation is difficult, as the definition remains both subjective and ill-defined in the clinical context. As our understanding of the ejaculatory pathway has improved, new opportunities to treat the condition have evolved with mixed results. In this review, we explore some of these controversies surrounding the aetiology, diagnosis, and treatment of this condition and discuss potential novel therapeutic options."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-2084.html",
            "name": "Premature ejaculation: challenging new and the old concepts"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Premature ejaculation: challenging new and the old concepts </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=13152 data-id=12150 data-downloads="" data-views="" data-scholar="10.12688/f1000research.12150.1" data-recommended="" data-doi="10.12688/f1000research.12150.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-2084/v1/pdf?article_uuid=aaad83d5-9adf-4666-8d6e-14d5c966dd0a" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-12150-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-12150-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-12150-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Kalejaiye O, Almekaty K, Blecher G and Minhas S. Premature ejaculation: challenging new and the old concepts [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2084 (<a class=new-orange href="https://doi.org/10.12688/f1000research.12150.1" target=_blank>https://doi.org/10.12688/f1000research.12150.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-12150-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=12150 id=track-article-signin-12150 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/12150?target=/articles/6-2084.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=13152 /> <input name=articleId type=hidden value=12150 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Premature ejaculation: challenging new and the old concepts</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:o.kalejaiye@nhs.net" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Odunayo Kalejaiye</span></a><a href="https://orcid.org/0000-0003-4065-0801" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-4065-0801</div><sup>1</sup>,&nbsp;</span><span class="">Khaled Almekaty<sup>1,2</sup>,&nbsp;</span><span class="">Gideon Blecher<sup>1</sup>,&nbsp;</span><span class="">Suks Minhas<sup>1</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:o.kalejaiye@nhs.net" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Odunayo Kalejaiye</span></a><a href="http://orcid.org/0000-0003-4065-0801" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-4065-0801</div><sup>1</sup>,&nbsp;</span><span class="">Khaled Almekaty<sup>1,2</sup>,&nbsp;</span><span class="">Gideon Blecher<sup>1</sup>,&nbsp;</span><span class="">Suks Minhas<sup>1</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 04 Dec 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.12150.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Andrology, University College London Medical School, London, W1G 8PH, UK<br/> <sup>2</sup> Urology Department, University of Tanta, Tanta, Egypt<br/> <p> <div class=margin-bottom> Odunayo Kalejaiye <br/> <span>Roles: </span> Writing – Original Draft Preparation </div> <div class=margin-bottom> Khaled Almekaty <br/> <span>Roles: </span> Writing – Review & Editing </div> <div class=margin-bottom> Gideon Blecher <br/> <span>Roles: </span> Writing – Review & Editing </div> <div class=margin-bottom> Suks Minhas <br/> <span>Roles: </span> Conceptualization, Supervision, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=28422-28388></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=28423-28389></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Premature ejaculation remains a difficult condition to manage for patients, their partners, and the clinician. Whilst prevalence rates are estimated to be 20–40%, determining a diagnosis of premature ejaculation is difficult, as the definition remains both subjective and ill-defined in the clinical context. As our understanding of the ejaculatory pathway has improved, new opportunities to treat the condition have evolved with mixed results. In this review, we explore some of these controversies surrounding the aetiology, diagnosis, and treatment of this condition and discuss potential novel therapeutic options. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Premature ejaculation, Treatment, Aetiology, Diagnosis, Physiology </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Odunayo Kalejaiye (<a href="mailto:o.kalejaiye@nhs.net">o.kalejaiye@nhs.net</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Odunayo Kalejaiye </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Kalejaiye O <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Kalejaiye O, Almekaty K, Blecher G and Minhas S. Premature ejaculation: challenging new and the old concepts [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2084 (<a href="https://doi.org/10.12688/f1000research.12150.1" target=_blank>https://doi.org/10.12688/f1000research.12150.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 04 Dec 2017, <b>6</b>(F1000 Faculty Rev):2084 (<a href="https://doi.org/10.12688/f1000research.12150.1" target=_blank>https://doi.org/10.12688/f1000research.12150.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 04 Dec 2017, <b>6</b>(F1000 Faculty Rev):2084 (<a href="https://doi.org/10.12688/f1000research.12150.1" target=_blank>https://doi.org/10.12688/f1000research.12150.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d51130e182>Introduction</h2><p class="" id=d51130e185>Premature ejaculation (PE) is a complex and poorly understood condition which can be difficult to manage for both the clinician and the patient. In this review, we will challenge some of the accepted theories and treatments associated with this condition and explore the current management options and potential treatments.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d51130e191>Does the concept of early ejaculation exist?</h2><p class="" id=d51130e194>Mammals ejaculate quickly to enhance their ability to procreate with multiple partners and spread their genetic material. In humans, sexual intercourse not only allows us to fulfil our reproductive potential but also has important effects on our quality of life. As boys reach puberty and start engaging in sexual activity, their time to ejaculation and their perceived control over their ejaculation change over time<sup><a href="#ref-1">1</a></sup>. We accept this to be a normal part of sexual maturity; however, we may define the same features as a sign of PE in an adult. In addition, ejaculation control and time are dependent on the male, his partner, and the sexual situation<sup><a href="#ref-2">2</a>–<a href="#ref-4">4</a></sup>. Early ejaculation is not necessarily always associated with lack of sexual enjoyment, and the perception of a sexual dysfunction secondary to PE may be heavily influenced by social factors<sup><a href="#ref-5">5</a>–<a href="#ref-7">7</a></sup>. We also know that social media, cultural attitudes, and abstinence can all affect sexual function<sup><a href="#ref-5">5</a>–<a href="#ref-7">7</a></sup>. Therefore, defining PE as a pathological condition may not necessarily be correct. We should use these concepts to challenge whether PE truly exists or whether it has arisen as a result of men having unrealistic concepts of sexual function which are based on social conditioning, especially the use of pornography. PE is a multimillion-dollar industry and therefore the pharmaceutical industry must be challenged as to whether medicalising PE benefits our patients or whether they would be best served with psycho-sexual counselling<sup><a href="#ref-1">1</a></sup>. In addition, the literature rarely assesses or medicates the female partners.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d51130e229>Prevalence</h2><p class="" id=d51130e232>PE is estimated to affect 20–40% of the general population, although only 4–5% may fulfil the International Society of Sexual Medicine (ISSM) definition for this<sup><a href="#ref-8">8</a>–<a href="#ref-13">13</a></sup>. Nathan <i>et al</i>. reported a prevalence of 35% based on the <i>Diagnostic and Statistical Manual of Mental Disorders</i>, third edition, Text Revision (DSM-III-TR) definition<sup><a href="#ref-3">3</a></sup>. In an Italian telephone survey, 14.7% of the calls were regarding PE and peak age was 26–35 years<sup><a href="#ref-14">14</a></sup>. Women called less frequently about PE. Similar results were obtained from a study on subjects contacting a UK-based sexual advice charity by email or telephone<sup><a href="#ref-2">2</a></sup>. Although most visitors to the charity’s website were from the UK, significant proportions were from the USA, Singapore, Canada, and India. PE was reported by 16% contacting the charity, and the peak age in men was 31–40 years old<sup><a href="#ref-2">2</a></sup>. PE was more commonly reported by men outside the UK, especially from the Indian subcontinent. The huge variability in the reported prevalence is due to the different methods with which PE is defined, which include questionnaires, self-reports, and several expert panel definitions<sup><a href="#ref-8">8</a>–<a href="#ref-11">11</a></sup>. Despite the variability in reported prevalence rates, a consistently lower proportion of men seek treatment<sup><a href="#ref-15">15</a>,<a href="#ref-16">16</a></sup>. This may reflect embarrassment and the perceived stigma attached to the condition.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d51130e282>Physiology</h2><p class="" id=d51130e285>Ejaculation is a normal part of male sexual function and consists of two coordinated neurological reflexes: emission and ejection<sup><a href="#ref-17">17</a></sup>. Orgasm is separate but occurs simultaneously<sup><a href="#ref-18">18</a></sup>. Emission involves contractions of the seminal vesicles and prostate and results in expulsion of sperm and seminal fluid into the posterior urethra<sup><a href="#ref-19">19</a></sup>. This is mediated by the sympathetic nervous system (T10–L2). Ejection involves the pulsatile contractions of the bulbocavernosus and pelvic floor muscles with relaxation of the external urinary sphincter<sup><a href="#ref-19">19</a></sup>. This is mediated by somatic nerves (S2–4) and involves the sympathetic nervous system with limited voluntary control<sup><a href="#ref-19">19</a></sup>. These reflexes are stimulated by sensory input from nerve endings in the glans penis, which are relayed via the sacral spinal cord to the sensory cerebral cortex<sup><a href="#ref-17">17</a></sup>. The pathway involves central serotonergic and dopaminergic neurons with secondary involvement of cholinergic, adrenergic, oxytocinergic, and gamma aminobutyric acid (GABA) neurons<sup><a href="#ref-19">19</a></sup>.</p><p class="" id=d51130e317>Dopamine and serotonin are essential neurotransmitters; dopamine promotes seminal emission and ejaculation via D2 receptors, while serotonin is inhibitory via the serotonin receptors (5-HT)<sup><a href="#ref-19">19</a></sup>. Stimulation of the 5-HT<sub>2c</sub> receptor results in ejaculatory delay in rats, whereas stimulation of the post-synaptic 5-HT<sub>1A</sub> receptors results in shortening of ejaculatory latency time<sup><a href="#ref-8">8</a>,<a href="#ref-19">19</a></sup>. It has been postulated that PE is due to hyposensitivity of 5-HT<sub>2C</sub> or hypersensitivity of 5-HT<sub>1A</sub> receptors or both. The role of oxytocin is less well established and has been found to have a stimulatory effect on ejaculation in rat models and reduces ejaculatory latency times<sup><a href="#ref-8">8</a>,<a href="#ref-20">20</a></sup>. This may be as a result of modulating the action of the 5-HT<sub>1A</sub> receptors<sup><a href="#ref-21">21</a></sup>.</p><p class="" id=d51130e358>The influence of hormones is less clear. Some animal models have suggested that cerebral dopamine and serotonin may interact with the hypothalamic-pituitary-thyroid axis<sup><a href="#ref-22">22</a>–<a href="#ref-24">24</a></sup>. Hyperthyroid rats were found to have shorter times to first ejaculation compared with controls<sup><a href="#ref-25">25</a></sup>. A small study by Carani <i>et al</i>. found a significant correlation between PE and hyperthyroid men, which fell dramatically, from 50 to 15%, following treatment<sup><a href="#ref-26">26</a></sup>. This would support a possible role for the thyroid hormones in ejaculation. However, other studies have suggested that there is a role only in acquired PE and this is a rare cause<sup><a href="#ref-27">27</a>,<a href="#ref-28">28</a></sup>.</p><p class="" id=d51130e386>A growing area in the aetiology of PE is its possible association with prostatitis. Sereponi <i>et al</i>. investigated the prevalence of chronic prostatitis in 46 men with PE and compared this group with an age-matched group of 30 healthy men<sup><a href="#ref-29">29</a></sup>. Prostatic inflammation and chronic bacterial prostatitis were found in 56.5% and 47.5% (respectively) of men with PE. In addition, 28.2% with PE were found to have one or more clinical symptoms of prostatitis. This study has been followed by several studies which have reviewed the effect of treating prostatitis on PE<sup><a href="#ref-30">30</a>,<a href="#ref-31">31</a></sup>. Treatment of prostatitis with a month of antibiotics based on culture sensitivities appears to increase ejaculatory latency times (2.6-fold) and control over ejaculation (83.9%)<sup><a href="#ref-30">30</a>,<a href="#ref-31">31</a></sup>. There was no recurrence of PE at a follow-up of 4 months<sup><a href="#ref-30">30</a>,<a href="#ref-31">31</a></sup>. Antibiotics appear to be most effective in men with acquired PE and where there are at least 19 pus cells per high-powered field in expressed prostate secretions<sup><a href="#ref-31">31</a></sup>. The mechanism remains poorly understood, but it has been suggested that prostatic inflammation may alter sensation and therefore the ejaculatory reflex<sup><a href="#ref-32">32</a></sup>. Although the evidence may still be growing, the assessment of the prostate appears to be a useful adjunct to the management of PE. However, as always, we must balance our use of antibiotics with our responsibility as antibiotic stewards in the growing international antibiotic crisis.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d51130e429>How to define premature ejaculation</h2><p class="" id=d51130e432>Early definitions of PE were criticised for their inconsistency and often having vague definitions subject to the clinician’s interpretation<sup><a href="#ref-33">33</a>,<a href="#ref-34">34</a></sup>. This has led to heterogeneous studies, adversely affecting both research and valid information regarding prevalence of the condition<sup><a href="#ref-33">33</a>,<a href="#ref-34">34</a></sup>. In 1980, the American Psychiatric Association published the DSM-III-TR, which has clearly defined PE albeit with many flaws<sup><a href="#ref-35">35</a></sup>. This definition (<a href="#T1">Table 1</a>) has been revised several times, and the current, fifth edition has corrected much of the earlier ambiguity (<a href="#T1">Table 1</a>)<sup><a href="#ref-36">36</a></sup>.</p><div class="table-wrap panel clearfix"><a name=T1 class=n-a></a><div class=caption><h3>Table 1. DSM-V-TR definition of premature ejaculation<sup><a href="#ref-36">36</a></sup>.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d51130e479 class=n-a></a><tbody><a name=d51130e481 class=n-a></a><tr><a name=d51130e483 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e485 class=n-a></a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Persistent/recurrent ejaculation with minimal sexual stimulation before or shortly after penetration and before the person wishes it<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Clinician should take into account factors affecting the duration of the excitation phase (for example, age, novelty of sexual<br class=br>partner/situation, and recent frequency of sexual activity)<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Disturbance causes distress or interpersonal difficulty<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Premature ejaculation not exclusively a result of direct effects of a substance (that is, opioid withdrawal)</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d51130e501 class=n-a></a><p id=d51130e503> DSM-V-TR, <i>Diagnostic and Statistical Manual of Mental Disorders</i>, fifth edition, Text Revision</p></div></div></div><p class="" id=d51130e512>This definition remains largely contentious with many ongoing criticisms. The absence of time criteria in the definition opens it up to misinterpretation by clinicians. This leads to inconsistencies in data collection and difficulty making direct comparisons between studies because of heterogeneous patient populations. This is illustrated by two studies using the DSM-V-TR definition (unchanged from version IV), which revealed significant overlap between the group defined as having PE and the group without PE<sup><a href="#ref-37">37</a>–<a href="#ref-40">40</a></sup>. A total of 13–25% of men with a diagnosis of PE according to the definition had intravaginal latency times of 4–25 minutes. In the study by Giuliano <i>et al</i>., 12.1% defined as not having PE had intravaginal latency times of less than 2 minutes<sup><a href="#ref-39">39</a></sup>.</p><p class="" id=d51130e529>A further criticism of the definition is that clinicians are asked to consider factors which may affect the excitation phase, such as age<sup><a href="#ref-33">33</a></sup>. However, there is no consistent evidence that age, novelty of partner, or relationship duration has any effect on ejaculatory latency times<sup><a href="#ref-41">41</a>,<a href="#ref-42">42</a></sup>. In a large global phone and email survey, men younger than 40 were significantly more likely to report PE<sup><a href="#ref-2">2</a></sup>. However, in a study of sexual behaviours and attitudes in the USA, the reverse was found<sup><a href="#ref-4">4</a></sup>.</p><p class="" id=d51130e552>The last major criticism is the absence of criteria for how frequently or the duration over which rapid ejaculation should occur before it may be defined as problematic<sup><a href="#ref-33">33</a></sup>. A man with frequent sexual engagement who occasionally experiences rapid ejaculation may not be bothered, whereas a man with infrequent sexual opportunity may be bothered by a single episode of rapid ejaculation. The definition does not clarify which subject should be diagnosed as having PE. The ISSM convened a panel of international experts to produce a new evidence-based definition (see <a href="#T2">Table 2</a><sup><a href="#ref-13">13</a>,<a href="#ref-43">43</a>,<a href="#ref-44">44</a></sup> for the current one) which would address most of the inconsistencies of earlier definitions.</p><div class="table-wrap panel clearfix"><a name=T2 class=n-a></a><div class=caption><h3>Table 2. International Society of Sexual Medicine definition of premature ejaculation (2014)<sup><a href="#ref-13">13</a>,<a href="#ref-43">43</a>,<a href="#ref-44">44</a></sup>.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d51130e592 class=n-a></a><tbody><a name=d51130e594 class=n-a></a><tr><a name=d51130e596 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e598 class=n-a></a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Ejaculation which always or nearly always occurs prior to or within about 1 minute of vaginal penetration from first sexual<br class=br>experiences (lifelong premature ejaculation) or a clinically bothersome reduction in latency time, often to about 3 minutes or less<br class=br>(acquired premature ejaculation)<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Inability to delay ejaculation on all or nearly all vaginal penetrations<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Negative personal consequences such as distress, bother, frustration, and/or the avoidance of sexual intimacy</td></tr></tbody></table></div><p class="" id=d51130e612>The main difficulties with this definition are the method of measuring the latency time and how to define a normal or abnormal time. The concept of the intravaginal ejaculatory latency time (IELT) was introduced by Waldinger <i>et al</i>.<sup><a href="#ref-5">5</a>,<a href="#ref-45">45</a></sup> in 1994. This is the time from vaginal penetration to ejaculation. It is a useful measurement tool in PE studies and may be either estimated by the male or his partner or measured directly with the use of a stopwatch. Several studies have suggested an acceptable correlation between estimated times<sup><a href="#ref-46">46</a>,<a href="#ref-47">47</a></sup>. There was a tendency for men to overestimate their IELT<sup><a href="#ref-6">6</a>,<a href="#ref-46">46</a>,<a href="#ref-47">47</a></sup>. This would allow the use of estimated IELT measures in clinical practice instead of measured IELT which may not be practical for couples. However, the study by Pryor <i>et al</i>., which compared, estimated, and measured IELTs, based PE definition on the DSM-IV-TR criteria, which is an inherent flaw in the study<sup><a href="#ref-46">46</a></sup>. This suggests that the estimated and measured IELTs are equivocal and erroneous, and we may need to repeat studies using the ISSM definitions for PE. Two large international population studies have provided useful information on IELT in the general population<sup><a href="#ref-5">5</a>,<a href="#ref-6">6</a></sup>. Both revealed a positively skewed distribution in IELT, and median times were 5.4 minutes (range of 0.55–44.1) and 6 minutes (range of 0.1–52.7). There was significant variability across the countries involved. This may suggest that IELT definitions need to be adjusted depending on the ethnic mix of the study population. In addition, it provides a useful counselling tactic to reassure a male patient that he is actually within the normal distribution. However, studies which have analysed IELT in the general population have not included ethnically diverse populations. A study from the UK reported that the highest incidence of PE was in men from Asian and Islamic backgrounds, which may reflect a genetic or a cultural aetiology<sup><a href="#ref-7">7</a></sup>. More studies are required to define normal IELT in these populations.</p><p class="" id=d51130e661>The first study revealed a significant reduction in IELT with age:</p><div class=list><a name=d51130e664 class=n-a></a><ul><li><p id=d51130e668>Age 18–30: IELT of 6.5 minutes</p></li><li><p id=d51130e674>Age 31–50: IELT of 5.4 minutes</p></li><li><p id=d51130e680>Age &gt;50: IELT of 4.3 minutes<sup><a href="#ref-5">5</a></sup></p></li></ul></div><p class="" id=d51130e688>The use of the 0.5 and 2.5 percentile is an accepted method of defining disease within a skewed distribution<sup><a href="#ref-48">48</a></sup>. These two studies, therefore, have defined an abnormal IELT as being 1 minute<sup><a href="#ref-5">5</a>,<a href="#ref-7">7</a>,<a href="#ref-46">46</a></sup>. This has been incorporated within the ISSM PE definition<sup><a href="#ref-44">44</a></sup> and has been supported in PE studies where 77–92% of men with PE generally ejaculate within 60 seconds<sup><a href="#ref-47">47</a>,<a href="#ref-49">49</a>,<a href="#ref-50">50</a></sup>.</p><p class="" id=d51130e720>The use of IELT is not without inherent problems. The data collected using IELT are usually based on either men with lifelong PE (LPE) or heterosexual men within stable relationships engaging only in vaginal penetrative sexual intercourse<sup><a href="#ref-33">33</a></sup>. This limits its general applicability to clinical populations. In addition, the act of measuring ejaculatory latency itself may affect sexual performance either positively or negatively. This is a factor which may be difficult to account for or quantify within clinical trials or medical practice.</p><p class="" id=d51130e727>The European Association of Urology (EAU) guidelines mention both definitions; however, it recommends that the diagnosis of PE include self-estimated IELT, perceived control, and interpersonal difficulty due to ejaculatory dysfunction<sup><a href="#ref-51">51</a></sup>. The American Association of Urology mentions the DSM-IV-TR in its discussion on PE definitions<sup><a href="#ref-52">52</a></sup>. However, it defines PE as “ejaculation that occurs sooner than desired, either before or shortly after penetration, causing distress to either one or both partners”<sup><a href="#ref-52">52</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d51130e746>Validated questionnaires</h2><p class="" id=d51130e749>Several validated questionnaires, which are mainly for use in clinical trials, have been developed<sup><a href="#ref-53">53</a>–<a href="#ref-56">56</a></sup>. Whilst they are useful adjuncts in clinical assessment and measuring the impact of treatment on PE, they are not without limitations, and they are used to assess LPE and men who have vaginal sexual intercourse<sup><a href="#ref-57">57</a></sup>. Currently, the EAU guidelines for PE recommend that both stopwatch-measured IELT and these types of questionnaire are not used in clinical practice<sup><a href="#ref-51">51</a></sup>.</p><div class=section><a name=d51130e767 class=n-a></a><h3 class=section-title>Premature Ejaculation Profile</h3><p class="" id=d51130e772>This questionnaire, developed by Patrick <i>et al</i>., assesses four domains of PE as defined according to the DSM-IV-TR<sup><a href="#ref-54">54</a>,<a href="#ref-57">57</a></sup>:</p><div class=list><a name=d51130e785 class=n-a></a><ul><li><p id=d51130e789>Perceived control over ejaculation</p></li><li><p id=d51130e795>Personal distress related to ejaculation</p></li><li><p id=d51130e801>Interpersonal difficulty related to ejaculation</p></li><li><p id=d51130e807>Satisfaction with sexual intercourse<sup><a href="#ref-54">54</a></sup></p></li></ul></div><p class="" id=d51130e815>Each domain is assessed by using a single question, and the response is rated on a five-point scale from 0–5; higher scores indicate better functioning. This is a validated questionnaire with good test-retest reliability and moderate/strong correlation with stopwatch measurements of IELT<sup><a href="#ref-54">54</a>,<a href="#ref-57">57</a>,<a href="#ref-58">58</a></sup>. Validation was in populations from Europe and the USA<sup><a href="#ref-54">54</a></sup>. It has been used extensively in observational and pharmacological trials<sup><a href="#ref-54">54</a>,<a href="#ref-57">57</a></sup>. The main advantages are that it is quick to complete and is useful as a measure of response to treatment<sup><a href="#ref-58">58</a></sup>. However, there are no validated cut-off values and it uses a single question to determine the effect within each domain<sup><a href="#ref-57">57</a></sup>. This would seem to be a major limitation when compared with the International Index of Erectile Function, where the erectile dysfunction (ED) domain score is determined by five questions and the scores are then divided into categories, which determine ED severity<sup><a href="#ref-59">59</a></sup>.</p></div><div class=section><a name=d51130e853 class=n-a></a><h3 class=section-title>Index of Premature Ejaculation</h3><p class="" id=d51130e858>This questionnaire, developed by Althof <i>et al</i>., assesses three domains using 10 questions<sup><a href="#ref-53">53</a>,<a href="#ref-54">54</a>,<a href="#ref-58">58</a></sup>. It was validated in men with an IELT of not more than 1 minute<sup><a href="#ref-57">57</a></sup>. Validation studies revealed that the questionnaire has good validity and reliability<sup><a href="#ref-57">57</a></sup>. In this index, unlike in the PE Profile (PEP), each domain is assessed using several questions. Similar to the PEP, it does not have any validated cut-off values.</p></div><div class=section><a name=d51130e883 class=n-a></a><h3 class=section-title>Premature Ejaculation Diagnostic Tool</h3><p class="" id=d51130e888>This is a screening questionnaire with five questions and no domains<sup><a href="#ref-55">55</a>,<a href="#ref-57">57</a>,<a href="#ref-58">58</a></sup>. Validation was based on focus and interviews of men from the USA, Germany, and Spain<sup><a href="#ref-55">55</a></sup>. Data were collected from men with PE defined according to the DSM-IV-TR and an IELT of not more than 2 minutes, men reporting PE, and men reporting no PE<sup><a href="#ref-55">55</a></sup>. Validation revealed good reliability and validity<sup><a href="#ref-58">58</a></sup>. The total score is from 0 to 25<sup><a href="#ref-55">55</a>,<a href="#ref-58">58</a></sup>. A score of 8 indicates no PE, a score of 9–10 indicates possible PE, and a score of at least 11 indicates PE<sup><a href="#ref-55">55</a></sup>. This useful questionnaire allows a quick diagnosis of PE but does not provide objective evidence of response to treatment. McMahon <i>et al</i>. reported the prevalence of PE in the Asia-Pacific region by using self-reports and the Premature Ejaculation Diagnostic Tool (PEDT)<sup><a href="#ref-11">11</a></sup>. They found that only 40% with PE diagnosis using PEDT also reported having PE. This suggests limitations with both the questionnaire and the male definition of what constitutes PE (<a href="#T3">Table 3</a>)<sup><a href="#ref-11">11</a>,<a href="#ref-55">55</a>,<a href="#ref-57">57</a>,<a href="#ref-58">58</a></sup>.</p><div class="table-wrap panel clearfix"><a name=T3 class=n-a></a><div class=caption><h3>Table 3. Premature ejaculation questionnaires<sup><a href="#ref-11">11</a>,<a href="#ref-55">55</a>,<a href="#ref-57">57</a>,<a href="#ref-58">58</a></sup>.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d51130e972 class=n-a></a><thead><a name=d51130e974 class=n-a></a><tr><a name=d51130e976 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d51130e978 class=n-a></a>Questionnaire</th><th align=left colspan=1 rowspan=1 valign=top><a name=d51130e981 class=n-a></a>Number of<br class=br>questions</th><th align=left colspan=1 rowspan=1 valign=top><a name=d51130e986 class=n-a></a>Domain names</th><th align=left colspan=1 rowspan=1 valign=top><a name=d51130e989 class=n-a></a>Advantages</th><th align=left colspan=1 rowspan=1 valign=top><a name=d51130e992 class=n-a></a>Disadvantages</th></tr></thead><tbody><a name=d51130e997 class=n-a></a><tr><a name=d51130e999 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1001 class=n-a></a>Premature Ejaculation<br class=br>Profile</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1006 class=n-a></a>4</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1009 class=n-a></a>Control over<br class=br>ejaculation<br class=br>Satisfaction with<br class=br>sexual intercourse<br class=br>Personal distress<br class=br>Interpersonal<br class=br>distress</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1025 class=n-a></a>Quick to complete<br class=br>Assess treatment<br class=br>outcome</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1032 class=n-a></a>Validation with <i>Diagnostic and Statistical</i><br class=br><i>Manual of Mental Disorders</i>, fourth<br class=br>edition, Text Revision (DSM-IV-TR)<br class=br>Single question to assess each domain<br class=br>No cut-offs</td></tr><tr><a name=d51130e1048 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1050 class=n-a></a>Interprofessional<br class=br>education</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1055 class=n-a></a>10</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1058 class=n-a></a>Control<br class=br>Sexual satisfaction<br class=br>Distress</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1065 class=n-a></a>Quick to complete<br class=br>Assess treatment<br class=br>outcome<br class=br>Validated in men with<br class=br>intravaginal ejaculatory<br class=br>latency time ≤1 minute</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1078 class=n-a></a>No cut-offs</td></tr><tr><a name=d51130e1082 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1084 class=n-a></a>Premature Ejaculation<br class=br>Diagnostic Tool</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1089 class=n-a></a>5</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1092 class=n-a></a>None</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1095 class=n-a></a>Screening questionnaire<br class=br>Cut-off values available<br class=br>Quick to complete</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1102 class=n-a></a>May not correspond with self-report of<br class=br>premature ejaculation</td></tr></tbody></table></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d51130e1115>Management options: historical options</h2><p class="" id=d51130e1118>The current EAU guidelines for the management of PE suggest the use of pharmacotherapy as first-line treatment<sup><a href="#ref-51">51</a></sup>. This includes either the short-acting dapoxetine (DPX) on demand or other off-label antidepressants such as daily selective serotonin reuptake inhibitors (SSRIs). Tramadol and topical local anaesthetics may be used as weak alternatives to SSRIs; phosphodiesterase-5 inhibitors (PDE5is) should be used only in men with concomitant ED<sup><a href="#ref-51">51</a></sup>. Behavioural therapy should be used with pharmacotherapy (<a href="#T4">Table 4</a>)<sup><a href="#ref-60">60</a>,<a href="#ref-61">61</a></sup>.</p><div class="table-wrap panel clearfix"><a name=T4 class=n-a></a><div class=caption><h3>Table 4. Historic treatment options<sup><a href="#ref-60">60</a>,<a href="#ref-61">61</a></sup>.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d51130e1157 class=n-a></a><thead><a name=d51130e1159 class=n-a></a><tr><a name=d51130e1161 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d51130e1163 class=n-a></a>Drug</th><th align=left colspan=1 rowspan=1 valign=top><a name=d51130e1166 class=n-a></a>Mechanism of action</th><th align=left colspan=1 rowspan=1 valign=top><a name=d51130e1169 class=n-a></a>IELT fold increase<br class=br>versus baseline</th><th align=left colspan=1 rowspan=1 valign=top><a name=d51130e1174 class=n-a></a>Side effects</th></tr></thead><tbody><a name=d51130e1179 class=n-a></a><tr><a name=d51130e1181 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1183 class=n-a></a>Topical local anaesthesia</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1186 class=n-a></a>Reduces sensitivity of glans</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1189 class=n-a></a>EMLA: 5.6<br class=br>TEMPE: 3–6.3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1194 class=n-a></a>Partner hypoanaesthesia</td></tr><tr><a name=d51130e1198 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1200 class=n-a></a>Selective serotonin<br class=br>reuptake inhibitors (SSRIs)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1205 class=n-a></a>Block axonal reuptake of serotonin<br class=br>from synaptic cleft<br class=br>Result in enhanced transmission<br class=br>and stimulation of 5-HT<sub>2c</sub> receptors</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1217 class=n-a></a>Paroxetine: 2.68–11.6<br class=br>Dapoxetine: 3.6–4.3<br class=br>Citalopram: 1.2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1224 class=n-a></a>Nausea<br class=br>Diarrhoea<br class=br>Headache<br class=br>Dizziness</td></tr><tr><a name=d51130e1234 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1236 class=n-a></a>Tramadol</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1239 class=n-a></a>Inhibition of 5-HT reuptake</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1242 class=n-a></a>3.3–5.6 </td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1245 class=n-a></a>Addiction<br class=br>Somnolence<br class=br>Pruritus<br class=br>Nausea<br class=br>Serotonin syndrome if<br class=br>used with SSRI</td></tr><tr><a name=d51130e1259 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1261 class=n-a></a>Phosphodiesterase-5<br class=br>inhibitor (PDE5i)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1266 class=n-a></a>Reduces contractile response of<br class=br>seminal vesicles and vas deferens</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1271 class=n-a></a>Sildenafil: 2.7–3.9<br class=br>Vardenafil: 6.5</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1276 class=n-a></a>Headache<br class=br>Flushing</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d51130e1286 class=n-a></a><p id=d51130e1288> 5-HT, 5-hydroxytryptamine; EMLA, eutectic mixture of local anaesthetics; IELT, intravaginal ejaculatory latency time; TEMPE, topical eutectic mixture for premature ejaculation.</p></div></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d51130e1297>Behavioural therapy</h2><p class="" id=d51130e1300>The aim of behavioural therapy is the development of sexual skills over time, which allows the male to delay ejaculation, increase sexual confidence, and reduce performance anxiety or stress<sup><a href="#ref-61">61</a></sup>. There are two types of behavioural therapy: psychotherapy and physical techniques<sup><a href="#ref-62">62</a></sup>.</p><p class="" id=d51130e1311>Psychotherapy uses counselling to identify and correct any interpersonal problems, which may have precipitated or be contributing to PE<sup><a href="#ref-8">8</a>,<a href="#ref-62">62</a></sup>. Physical therapies involve a variety of exercises to slowly increase the degree of genital stimulation over time, which allows the male to gain control over his ejaculation<sup><a href="#ref-8">8</a>,<a href="#ref-62">62</a></sup>. This includes ‘stop-start’, ‘squeeze’, ‘sensate focus’, and pelvic floor muscle rehabilitation<sup><a href="#ref-8">8</a>,<a href="#ref-62">62</a></sup>. The efficacy of these studies is difficult to assess, as their inclusion criteria do not always meet ISSM PE definitions; they include various types of treatments with either unreported or variable treatment duration<sup><a href="#ref-8">8</a>,<a href="#ref-62">62</a></sup>. In addition, the number of men receiving treatment is small; the method of IELT measurement and follow-up is limited. Despite these reservations, behavioural therapy appears to improve IELT when compared with placebo in two out of four studies in a recent systematic review<sup><a href="#ref-62">62</a></sup>. However, the picture is more mixed when behavioural therapy was compared with active drugs (that is, antidepressants); there was a trend towards improved IELT with active drugs or no significant differences<sup><a href="#ref-8">8</a>,<a href="#ref-9">9</a>,<a href="#ref-62">62</a></sup>. There is a need for more high-quality studies which are appropriately powered to demonstrate an effect using contemporary PE definitions. The combination of behavioural therapy with drug treatment (for example, DPX, chlorpromazine, paroxetine, and citalopram) has shown a significant but small improvement in outcome measures (that is, IELT) compared with the active drug alone in the three studies included in the systematic review<sup><a href="#ref-62">62</a></sup>. The outcome measures included IELT in two studies and a validated questionnaire in one study. The improvement in IELT was 0.5–1 minute. Cormio <i>et al</i>. published the results of their well-designed open-label prospective randomised study in 2015<sup><a href="#ref-63">63</a></sup>. The inclusion criterion was based on the ISSM definition of PE. They compared outcomes of on-demand DPX with on-demand DPX plus behavioural therapy. Both groups had a significant improvement in IELT; however, the combination therapy resulted in a further 102- and 210-second increase at 12 and 24 weeks, respectively<sup><a href="#ref-63">63</a></sup>. In addition, 80% within the combination group no longer had PE at 24 weeks (versus zero in the DPX-alone group) based on the validated questionnaire PEDT.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d51130e1375>Topical eutectic mixture for premature ejaculation</h2><p class="" id=d51130e1378>Topical local anaesthetic agents are the oldest treatments for PE. However, they are often criticised for not being specifically optimised for PE, for being slow-acting, and for requiring the use of condoms to prevent partner transference and resultant partner hypoanaesthesia<sup><a href="#ref-64">64</a>,<a href="#ref-65">65</a></sup>. Topical eutectic mixture for PE (TEMPE, Plethora Solutions Ltd, Chalgrove, UK) was designed specifically for PE. It consists of 7.5 mg of lignocaine and 2.5 mg of prilocaine dissolved within a solution, which prevents penetration into the keratinised skin of the penile shaft<sup><a href="#ref-66">66</a></sup>. This results in a localised desensitising effect<sup><a href="#ref-66">66</a></sup>. The efficacy has been evaluated in two phase III placebo-controlled multicentre studies<sup><a href="#ref-64">64</a>,<a href="#ref-66">66</a></sup>. In total, 530 men with mainly LPE according to the ISSM definition were randomly assigned to TEMPE or placebo in 69 centres across Europe and North America<sup><a href="#ref-64">64</a>,<a href="#ref-66">66</a></sup>. A 6.3- and 4.6-fold increase in IELT was observed in both studies, respectively. There was also a significant improvement in the interprofessional education (IPE) domain scores in both studies<sup><a href="#ref-64">64</a>,<a href="#ref-66">66</a></sup>. The odds of achieving an IELT of over 1 minute and over 2 minutes were 9 times and 12.8 times greater with TEMPE compared with placebo, respectively<sup><a href="#ref-66">66</a></sup>. However, although after 3 months 90% of men receiving TEMPE achieved a mean IELT of over 1 minute, 54% in the placebo group achieved the same<sup><a href="#ref-66">66</a></sup>. This suggests a very strong placebo effect, which again calls into question how much we truly understand about this condition and controversially whether it exists as a true medical condition.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d51130e1429>Selective serotonin reuptake inhibitors</h2><p class="" id=d51130e1432>SSRIs inhibit axonal reuptake of serotonin from the synaptic cleft of central and peripheral serotonergic neurons by 5-HT transporters, resulting in enhanced 5-HT transmission and stimulation of post-synaptic membrane 5-HT<sub>2c</sub> receptors<sup><a href="#ref-19">19</a></sup>. SSRIs may be used daily or on demand. A recent meta-analysis evaluated long-acting (paroxetine, citalopram, fluoxetine, and fluvoxamine) and short-acting SSRIs<sup><a href="#ref-61">61</a></sup>. Paroxetine was associated with the best efficacy, with an 11.6-fold increase in IELT in one study<sup><a href="#ref-61">61</a></sup>. The use of an on-demand regime has been associated with less ejaculatory delay<sup><a href="#ref-67">67</a>–<a href="#ref-70">70</a></sup>. Adverse effects are usually mild and include fatigue, yawning, nausea, and loose stools<sup><a href="#ref-61">61</a></sup>. ED and libido reduction have also been reported, though less frequently compared with men using the drugs for depression<sup><a href="#ref-61">61</a>,<a href="#ref-71">71</a></sup>. Men must be cautioned about SSRI withdrawal syndrome with abrupt drug cessation<sup><a href="#ref-61">61</a></sup>.</p><p class="" id=d51130e1473>DPX is currently the only SSRI marketed specifically and licenced for the treatment of PE. It has the largest efficacy and safety database, having been studied in over 6,000 men in a variety of well-conducted, placebo-controlled trials<sup><a href="#ref-64">64</a></sup>. A recent meta-analysis of PE treatments revealed that DPX is associated with a 3- to 4.3-fold increase in IELT over baseline in three large placebo-controlled trials<sup><a href="#ref-61">61</a>,<a href="#ref-64">64</a></sup>. DPX has a good safety profile with side effects similar to those observed with other SSRIs<sup><a href="#ref-61">61</a>,<a href="#ref-72">72</a></sup>. In a large open-label observational study comparing DPX with alternative treatments for PE (including other SSRIs, condoms, and behavioural therapy), DPX had a higher incidence of adverse events (12% versus 8.95%)<sup><a href="#ref-72">72</a></sup>. The highest incidence of adverse events was observed in men over 65 using DPX and men 30–39 years old using other therapies<sup><a href="#ref-72">72</a></sup>.</p><p class="" id=d51130e1502>Despite the high efficacy of SSRIs and associated low rate of adverse events, the proportions of men who stopped using DPX were 79.1% within 6 months and 90.1% at 2 years<sup><a href="#ref-73">73</a></sup>. The commonest reasons for discontinuation were the following:</p><div class=list><a name=d51130e1509 class=n-a></a><ul><li><p id=d51130e1513>Disappointment that PE was incurable and tablets needed for every sexual encounter</p></li><li><p id=d51130e1519>Side effects</p></li><li><p id=d51130e1525>Perceived poor efficacy</p></li><li><p id=d51130e1531>Search for alternative treatments</p></li><li><p id=d51130e1537>Unknown<sup><a href="#ref-73">73</a></sup></p></li></ul></div><p class="" id=d51130e1546>This suggests that more efficacious therapies are still required. Although similar complaints may be expressed by men with ED, ultimately the insertion of a penile prosthesis will allow a man to have sexual intercourse. Unfortunately, this is not the case with men with PE.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d51130e1552>Phosphodiesterase-5 inhibitors</h2><p class="" id=d51130e1555>PDE5is are the gold-standard first treatment for men with ED. However, their role in PE remains unclear. PDE5 is expressed in the prostate, vas deferens, and seminal vesicles and may have a physiological role in ejaculation<sup><a href="#ref-74">74</a>–<a href="#ref-76">76</a></sup>. The coexistence of ED and PE is common, occurring in up to 50% in some studies<sup><a href="#ref-77">77</a>–<a href="#ref-80">80</a></sup>. In addition, 33.3% of men may confuse the two conditions<sup><a href="#ref-81">81</a></sup>. This is not surprising. Men with ED require higher levels of arousal to attain an erection or may attempt to rush sexual intercourse prior to loss of their erection<sup><a href="#ref-80">80</a></sup>. Both of these situations will predispose them to a reduction in ejaculatory control and possible PE. Conversely, men with PE require a reduction in arousal to control ejaculation, which may worsen erectile function<sup><a href="#ref-80">80</a></sup>. Sexual dysfunction is also associated with performance anxiety, which may worsen erectile function<sup><a href="#ref-13">13</a>,<a href="#ref-82">82</a></sup>.</p><p class="" id=d51130e1592>Most studies appear to suggest that the use of PDE5is may be useful in the treatment of PE<sup><a href="#ref-83">83</a>–<a href="#ref-85">85</a></sup>. However, they have been criticised for their poor methodology<sup><a href="#ref-82">82</a></sup>. Two systematic reviews have failed to support the use of PDE5is in the treatment of PE except where PE coexists with ED<sup><a href="#ref-61">61</a>,<a href="#ref-82">82</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d51130e1617>Management options: novel agents</h2><div class=section><a name=d51130e1620 class=n-a></a><h3 class=section-title>DA-8031</h3><p class="" id=d51130e1625>DA-8031 is a potent SSRI with high affinity and selectivity for the serotonin transporter<sup><a href="#ref-86">86</a></sup>. DA-8031 inhibits the expulsion phase of ejaculation by modulating the activity of the bulbospongiosus muscle in male rats<sup><a href="#ref-86">86</a>,<a href="#ref-87">87</a></sup>. In addition, it is associated with reduced serotonin transporter occupancy, confirmed on positron emission tomography of the rat brain<sup><a href="#ref-87">87</a></sup>. This was recently evaluated in the first human trial to assess safety and tolerability after a single dose in healthy men<sup><a href="#ref-88">88</a></sup>. Men were randomly assigned to receive either the active drug or placebo. The drug was well tolerated up to the 80 mg dose. The commonest adverse events were nausea and hypotension. The authors found that a dose of 120 mg was associated with prolongation of the QT interval on electrocardiogram<sup><a href="#ref-88">88</a></sup>. This is potentially a very exciting drug for the future, and further studies are awaited (<a href="#T5">Table 5</a>).</p><div class="table-wrap panel clearfix"><a name=T5 class=n-a></a><div class=caption><h3>Table 5. Novel agents for the treatment of premature ejaculation.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d51130e1666 class=n-a></a><thead><a name=d51130e1668 class=n-a></a><tr><a name=d51130e1670 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d51130e1672 class=n-a></a>Drug</th><th align=left colspan=1 rowspan=1 valign=top><a name=d51130e1675 class=n-a></a>Mechanism of action</th></tr></thead><tbody><a name=d51130e1680 class=n-a></a><tr><a name=d51130e1682 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1684 class=n-a></a>DA8031</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1687 class=n-a></a>Selective serotonin reuptake inhibitor</td></tr><tr><a name=d51130e1691 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1693 class=n-a></a>Epelsiban</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1696 class=n-a></a>Oxytocin antagonist</td></tr><tr><a name=d51130e1700 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1702 class=n-a></a>IX-01</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1705 class=n-a></a>Oxytocin antagonist</td></tr><tr><a name=d51130e1709 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1711 class=n-a></a>Modafinil</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1714 class=n-a></a>Poorly understood: possible activation<br class=br>of central dopaminergic and<br class=br>serotonergic pathway<br class=br>Narcolepsy drug</td></tr><tr><a name=d51130e1724 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1726 class=n-a></a>Alpha-blockers</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1729 class=n-a></a>Inhibition at bladder neck<br class=br>Inhibition of seminal emission</td></tr><tr><a name=d51130e1736 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1738 class=n-a></a>Botulinum-A toxin</td><td align=left colspan=1 rowspan=1 valign=top><a name=d51130e1741 class=n-a></a>Unclear: may inhibit contraction of<br class=br>bulbospongiosus by blocking neural<br class=br>transmission</td></tr></tbody></table></div></div><div class=section><a name=d51130e1753 class=n-a></a><h3 class=section-title>Oxytocin antagonists</h3><p class="" id=d51130e1758>Oxytocin is a peptide hormone that is believed to shorten ejaculatory latency times through central and peripheral pathways in animal models<sup><a href="#ref-8">8</a>,<a href="#ref-20">20</a>,<a href="#ref-89">89</a></sup>. The ejaculatory delay observed with SSRIs may be mediated by alterations in the central release of oxytocin<sup><a href="#ref-90">90</a>,<a href="#ref-91">91</a></sup>. This has formed the basis of the development of oxytocin receptor antagonists. The first drug used in human clinical trials was epelsiban. This is a highly selective oxytocin receptor antagonist with rapid absorption and elimination<sup><a href="#ref-20">20</a></sup>. It had been shown to delay ejaculatory latency in animal models<sup><a href="#ref-20">20</a></sup>. In this multicentre study, men were randomly assigned to placebo or epelsiban (50 mg/150 mg)<sup><a href="#ref-20">20</a></sup>. Study inclusion was based on the ISSM definition of PE, and IELT was measured with the use of a stopwatch. There was no significant difference in the baseline IELT measurements between the groups. Following 8 weeks of treatment, there were no significant clinical or statistically significant differences in IELT between the groups. The authors speculated that efficacy may be linked to centrally acting oxytocin antagonist activity<sup><a href="#ref-20">20</a>,<a href="#ref-92">92</a>,<a href="#ref-93">93</a></sup>. There is some evidence from animal studies to support this hypothesis<sup><a href="#ref-20">20</a>,<a href="#ref-92">92</a>,<a href="#ref-94">94</a></sup>. This has led to the development of the most recent oxytocin antagonist, IX-01<sup><a href="#ref-89">89</a>,<a href="#ref-95">95</a></sup>. This is a small molecule with good central penetration and rapid absorption with potent antagonism of the oxytocin receptor<sup><a href="#ref-95">95</a></sup>. A total of 88 men with LPE were randomly assigned to either placebo or active drug (400 mg/800 mg). Inclusion appeared to be based on ISSM criteria. Following 8 weeks of treatment, IX-01 resulted in a 3-fold increase in IELT (1.6 in the placebo group). This improvement was observed as early as 2 weeks after starting treatment. The drug was well tolerated with no serious or severe adverse events; 21% reported at least one adverse event (30% in the placebo group). The dropout rate was high: 21% with the active drug and 27% in the placebo arm. This is obviously encouraging news for the field, and we should expect larger trials involving a more diverse population.</p></div><div class=section><a name=d51130e1823 class=n-a></a><h3 class=section-title>Modafinil</h3><p class="" id=d51130e1828>This is a drug used in the treatment of narcolepsy. Its mechanism of action is poorly understood but is thought to be via activation of central dopaminergic and serotonin pathways<sup><a href="#ref-65">65</a>,<a href="#ref-96">96</a></sup>. A sexual study in male rats has shown that the administration of D-modafinil resulted in a significant delay in ejaculation latency times<sup><a href="#ref-97">97</a></sup>. This effect may be mediated via an increase in serotonin release in the brain or spinal cord or an action on the dopamine system or both<sup><a href="#ref-98">98</a>–<a href="#ref-103">103</a></sup>.</p><p class="" id=d51130e1849>Tuken <i>et al</i>. evaluated the use of modafinil 100 mg in 55 men with LPE<sup><a href="#ref-104">104</a></sup>. Although PEP domain outcomes were significantly improved, there was only a modest increase in IELT, from 25 to 50 seconds<sup><a href="#ref-104">104</a></sup>. A pre-clinical study is underway to investigate the short-acting modafinil d-isomer for the treatment of PE<sup><a href="#ref-89">89</a></sup>.</p></div><div class=section><a name=d51130e1868 class=n-a></a><h3 class=section-title>α1-adrenoceptor antagonists</h3><p class="" id=d51130e1873>α1-adrenoceptor antagonists have a long history of use for the treatment of lower urinary tract symptoms (LUTS) with established efficacy. However, they are associated with documented side effects, which include ejaculatory dysfunction. They mediate ejaculatory dysfunction via two mechanisms:</p><div class=list><a name=d51130e1876 class=n-a></a><ul style="list-style-type: none"><li><p id=d51130e1883><span class=label>1. </span> Inhibition at the bladder neck, prostate, and urethra, resulting in retrograde ejaculation</p></li><li><p id=d51130e1892><span class=label>2. </span> Inhibition of seminal emission resulting in ejaculatory dysfunction<sup><a href="#ref-89">89</a></sup></p></li></ul></div><p class="" id=d51130e1900>In a placebo-controlled study by Cavallini, alfuzosin and terazosin were associated with a 50% rate of ejaculatory delay<sup><a href="#ref-105">105</a></sup>. A similar study by Başar <i>et al</i>., using only terazosin, found that 67% of men reported ejaculatory delay<sup><a href="#ref-106">106</a></sup>. A major criticism of both of these studies was that neither used IELT to define efficacy. Efficacy was based on patient impression of change and sexual satisfaction<sup><a href="#ref-89">89</a></sup>. These two studies are relatively historic studies and their PE definitions are unlikely to be compatible with current accepted definitions.</p><p class="" id=d51130e1918>Silodosin is a new, highly selective α1-adrenoceptor antagonist which has been associated with good efficacy for the treatment of LUTS but higher rates of ejaculatory dysfunction compared with other α1-adrenoceptor antagonists<sup><a href="#ref-107">107</a>–<a href="#ref-110">110</a></sup>. Sato <i>et al</i>. evaluated its use in the treatment of PE in a small prospective study of eight men<sup><a href="#ref-111">111</a></sup>. Inclusion criteria were based on the DSM-IV-TR definition. Efficacy outcomes were based on change in IELT and the PEP questionnaire domains. At the end of the 2-month treatment period, there was a significant improvement in IELT, from 3.4 to 10.1 minutes. In addition, all patients reported that their ejaculation problem was ‘much better’ or ‘slightly better’. Anejaculation (25%), reduced semen volume (37.5%), and pain during orgasm (87.5%) were common. This study offers an interesting and novel treatment for PE. However, there are several limitations. The most obvious limitation would be the use of the DSM-IV-TR definition, which allowed the inclusion of men who would not qualify as having PE according to the ISSM definition. This translated into a high baseline IELT at 3.4 minutes. In addition, 75% were on PDE5is, a known treatment modality for PE. In addition, there was a high rate of adverse events, which may correspond to a high dropout rate when translated into the typical young population with PE. Similar results were obtained in studies by Akin <i>et al</i>.<sup><a href="#ref-112">112</a></sup> and Sato <i>et al</i>.<sup><a href="#ref-111">111</a></sup>, where silodosin was compared with other α1-adrenoceptor antagonists<sup><a href="#ref-73">73</a></sup>. Ideally, before it is possible to fully assess the efficacy of silodosin, there must be a placebo-controlled trial with a more diverse PE population using the ISSM criteria.</p></div><div class=section><a name=d51130e1956 class=n-a></a><h3 class=section-title>Botulinum-A toxin</h3><p class="" id=d51130e1961>This neurotoxin is produced by the bacterium <i>Clostridium botulinum.</i> It selectively inhibits the release of acetylcholine from nerve endings, thereby blocking neural transmission when injected into muscle<sup><a href="#ref-89">89</a></sup>. It has revolutionised the management of detrusor instability. Serefoglu <i>et al</i>. have suggested that Botox may inhibit muscle contractions during the ejection phase of ejaculation when injected percutaneously into the bulbospongiosus muscles of male rats<sup><a href="#ref-113">113</a></sup>. This resulted in a significant increase in ejaculatory latency times. The effect peaked after 11 days and decreased sharply after 14 days. The difference in post-treatment ejaculatory latency between Botox and saline did not reach statistical significance.</p><p class="" id=d51130e1978>There are currently patents for the use of Botox injected into the penis, frenulum, glans, and prepuce for the treatment of PE<sup><a href="#ref-114">114</a></sup>. This is both surprising and alarming in the absence of human trials and only minimal scientific evidence where Botox was injected into the bulbospongiosus muscles. However, a phase II clinical trial in humans is underway and we await its results<sup><a href="#ref-89">89</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d51130e1993>Conclusions</h2><p class="" id=d51130e1996>PE is a common problem with variability in definitions and efficacy measures of drugs used for this condition. The real importance for future drug development is the unification of definitions of PE and an agreed standard for what are acceptable measures and inclusion criteria in the trial setting. There remains uncertainty in assessing the true value of some of the drugs we already use in the management of this condition. There are different definitions for PE, different efficacy measures, and poor methodology in clinical trials. In addition, the high discontinuation rates suggest that our patients remain dissatisfied with the treatments we currently offer. Furthermore, one must be cautious to define a pathological condition often associated with a high placebo effect.</p><p class="" id=d51130e1999>There are currently several novel agents which show promise for the future, but our optimism must be balanced against accepting suboptimal science and methodology in drug trials. PE continues to be the Cinderella of sexual medicine and requires funding and high-level research in both basic science and clinical trials. The oxytocin antagonists probably show the most future promise but data are still premature.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d51130e1 class=n-a></a><h2 class=main-title id=d51470>Competing interests</h2><p class=metadata-entry><a name=d51130e119 class=n-a></a><p id=d51130e120> No competing interests were disclosed.</p></p></div><div class=back-section><a name=d51130e1 class=n-a></a><h2 class=main-title id=d51472>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d51130e2006 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d51818>References</h2><div class="section ref-list"><a name=d51130e2006 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d51130e2013 class=n-a></a>Puppo V, Puppo G: Comprehensive review of the anatomy and physiology of male ejaculation: Premature ejaculation is not a disease. <i>Clin Anat.</i> 2016; <b>29</b>(1): 111–9. <a target=xrefwindow id=d51130e2021 href="http://www.ncbi.nlm.nih.gov/pubmed/26457680">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2024 href="http://dx.doi.org/10.1002/ca.22655">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d51130e2033 class=n-a></a>Tomlinson JM, Fernandes LC, Wylie KR: An e-mail and telephone helpline for sexual problems - results of a 2-year survey of men's sexual concerns. <i>Int J Clin Pract.</i> 2011; <b>65</b>(10): 1085–91. <a target=xrefwindow id=d51130e2041 href="http://www.ncbi.nlm.nih.gov/pubmed/21801284">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2044 href="http://dx.doi.org/10.1111/j.1742-1241.2011.02729.x">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d51130e2053 class=n-a></a>Nathan SG: The epidemiology of the DSM-III psychosexual dysfunctions. <i>J Sex Marital Ther.</i> 1986; <b>12</b>(4): 267–81. <a target=xrefwindow id=d51130e2061 href="http://www.ncbi.nlm.nih.gov/pubmed/3493350">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2064 href="http://dx.doi.org/10.1080/00926238608415413">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d51130e2073 class=n-a></a>Nicolosi A, Laumann EO, Glasser DB, <i> et al.</i>: Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors. <i>Urology.</i> 2004; <b>64</b>(5): 991–7. <a target=xrefwindow id=d51130e2084 href="http://www.ncbi.nlm.nih.gov/pubmed/15533492">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2087 href="http://dx.doi.org/10.1016/j.urology.2004.06.055">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1046273"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d51130e2096 class=n-a></a>Waldinger MD, Quinn P, Dilleen M, <i> et al.</i>: A multinational population survey of intravaginal ejaculation latency time. <i>J Sex Med.</i> 2005; <b>2</b>(4): 492–7. <a target=xrefwindow id=d51130e2107 href="http://www.ncbi.nlm.nih.gov/pubmed/16422843">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2110 href="http://dx.doi.org/10.1111/j.1743-6109.2005.00070.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1046273">F1000 Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d51130e2124 class=n-a></a>Waldinger MD, McIntosh J, Schweitzer DH: A five-nation survey to assess the distribution of the intravaginal ejaculatory latency time among the general male population. <i>J Sex Med.</i> 2009; <b>6</b>(10): 2888–95. <a target=xrefwindow id=d51130e2132 href="http://www.ncbi.nlm.nih.gov/pubmed/19627471">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2135 href="http://dx.doi.org/10.1111/j.1743-6109.2009.01392.x">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d51130e2144 class=n-a></a>Richardson D, Goldmeier D: Premature ejaculation--does country of origin tell us anything about etiology? <i>J Sex Med.</i> 2005; <b>2</b>(4): 508–12. <a target=xrefwindow id=d51130e2152 href="http://www.ncbi.nlm.nih.gov/pubmed/16422845">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2155 href="http://dx.doi.org/10.1111/j.1743-6109.2005.00074.x">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d51130e2164 class=n-a></a>Althof SE, McMahon CG, Waldinger MD, <i> et al.</i>: An Update of the International Society of Sexual Medicine's Guidelines for the Diagnosis and Treatment of Premature Ejaculation (PE). <i>Sex Med.</i> 2014; <b>2</b>(2): 60–90. <a target=xrefwindow id=d51130e2175 href="http://www.ncbi.nlm.nih.gov/pubmed/25356302">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2178 href="http://dx.doi.org/10.1002/sm2.28">Publisher Full Text </a> | <a target=xrefwindow id=d51130e2182 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4184677">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d51130e2191 class=n-a></a>Serefoglu EC, Yaman O, Cayan S, <i> et al.</i>: Prevalence of the complaint of ejaculating prematurely and the four premature ejaculation syndromes: results from the Turkish Society of Andrology Sexual Health Survey. <i>J Sex Med.</i> 2011; <b>8</b>(2): 540–8. <a target=xrefwindow id=d51130e2202 href="http://www.ncbi.nlm.nih.gov/pubmed/21054799">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2205 href="http://dx.doi.org/10.1111/j.1743-6109.2010.02095.x">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d51130e2214 class=n-a></a>Gao J, Zhang X, Su P, <i> et al.</i>: Prevalence and factors associated with the complaint of premature ejaculation and the four premature ejaculation syndromes: a large observational study in China. <i>J Sex Med.</i> 2013; <b>10</b>(7): 1874–81. <a target=xrefwindow id=d51130e2225 href="http://www.ncbi.nlm.nih.gov/pubmed/23651451">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2228 href="http://dx.doi.org/10.1111/jsm.12180">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d51130e2237 class=n-a></a>McMahon CG, Lee G, Park JK, <i> et al.</i>: Premature ejaculation and erectile dysfunction prevalence and attitudes in the Asia-Pacific region. <i>J Sex Med.</i> 2012; <b>9</b>(2): 454–65. <a target=xrefwindow id=d51130e2248 href="http://www.ncbi.nlm.nih.gov/pubmed/22023395">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2251 href="http://dx.doi.org/10.1111/j.1743-6109.2011.02507.x">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d51130e2261 class=n-a></a>Vakalopoulos I, Dimitriadis G, Varnava C, <i> et al.</i>: Prevalence of ejaculatory disorders in urban men: results of a random-sample survey. <i>Andrologia.</i> 2011; <b>43</b>(5): 327–33. <a target=xrefwindow id=d51130e2272 href="http://www.ncbi.nlm.nih.gov/pubmed/21729128">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2275 href="http://dx.doi.org/10.1111/j.1439-0272.2010.01079.x">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1157029"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d51130e2284 class=n-a></a>McMahon CG, Althof SE, Waldinger MD, <i> et al.</i>: An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. <i>J Sex Med.</i> 2008; <b>5</b>(7): 1590–606. <a target=xrefwindow id=d51130e2295 href="http://www.ncbi.nlm.nih.gov/pubmed/18466262">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2298 href="http://dx.doi.org/10.1111/j.1743-6109.2008.00901.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1157029">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d51130e2311 class=n-a></a>Simonelli C, Tripodi F, Cosmi V, <i> et al.</i>: What do men and women ask a helpline on sexual concerns? Results of an Italian telephone counselling service. <i>Int J Clin Pract.</i> 2010; <b>64</b>(3): 360–70. <a target=xrefwindow id=d51130e2322 href="http://www.ncbi.nlm.nih.gov/pubmed/20456175">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2325 href="http://dx.doi.org/10.1111/j.1742-1241.2009.02269.x">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d51130e2334 class=n-a></a>Spector IP, Carey MP: Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. <i>Arch Sex Behav.</i> 1990; <b>19</b>(4): 389–408. <a target=xrefwindow id=d51130e2342 href="http://www.ncbi.nlm.nih.gov/pubmed/2205172">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2345 href="http://dx.doi.org/10.1007/BF01541933">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d51130e2354 class=n-a></a>Grenier G, Byers ES: Rapid ejaculation: a review of conceptual, etiological, and treatment issues. <i>Arch Sex Behav.</i> 1995; <b>24</b>(4): 447–72. <a target=xrefwindow id=d51130e2362 href="http://www.ncbi.nlm.nih.gov/pubmed/7661658">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2365 href="http://dx.doi.org/10.1007/BF01541858">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d51130e2374 class=n-a></a>Wyllie MG, Hellstrom WJ: The link between penile hypersensitivity and premature ejaculation. <i>BJU Int.</i> 2011; <b>107</b>(3): 452–7. <a target=xrefwindow id=d51130e2382 href="http://www.ncbi.nlm.nih.gov/pubmed/20553259">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2385 href="http://dx.doi.org/10.1111/j.1464-410X.2010.09456.x">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d51130e2395 class=n-a></a>Jenkins LC, Mulhall JP: Delayed orgasm and anorgasmia. <i>Fertil Steril.</i> 2015; <b>104</b>(5): 1082–8. <a target=xrefwindow id=d51130e2403 href="http://www.ncbi.nlm.nih.gov/pubmed/26439762">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2406 href="http://dx.doi.org/10.1016/j.fertnstert.2015.09.029">Publisher Full Text </a> | <a target=xrefwindow id=d51130e2409 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4816679">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d51130e2418 class=n-a></a>Waldinger MD: The neurobiological approach to premature ejaculation. <i>J Urol.</i> 2002; <b>168</b>(6): 2359–67. <a target=xrefwindow id=d51130e2426 href="http://www.ncbi.nlm.nih.gov/pubmed/12441918">PubMed Abstract </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d51130e2435 class=n-a></a>Shinghal R, Barnes A, Mahar KM, <i> et al.</i>: Safety and efficacy of epelsiban in the treatment of men with premature ejaculation: a randomized, double-blind, placebo-controlled, fixed-dose study. <i>J Sex Med.</i> 2013; <b>10</b>(10): 2506–17. <a target=xrefwindow id=d51130e2446 href="http://www.ncbi.nlm.nih.gov/pubmed/23937679">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2449 href="http://dx.doi.org/10.1111/jsm.12272">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725057546"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d51130e2458 class=n-a></a>de Jong TR, Neumann ID: Moderate role of oxytocin in the pro-ejaculatory effect of the 5-HT<sub>1A</sub> receptor agonist 8-OH-DPAT. <i>J Sex Med.</i> 2015; <b>12</b>(1): 17–28. <a target=xrefwindow id=d51130e2469 href="http://www.ncbi.nlm.nih.gov/pubmed/25359190">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2472 href="http://dx.doi.org/10.1111/jsm.12742">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725057546">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d51130e2485 class=n-a></a>Carosa E, Di Sante S, Rossi S, <i> et al.</i>: Ontogenetic profile of the expression of thyroid hormone receptors in rat and human corpora cavernosa of the penis. <i>J Sex Med.</i> 2010; <b>7</b>(4 Pt 1): 1381–90. <a target=xrefwindow id=d51130e2496 href="http://www.ncbi.nlm.nih.gov/pubmed/20141582">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2499 href="http://dx.doi.org/10.1111/j.1743-6109.2009.01701.x">Publisher Full Text </a> | <a target=xrefwindow id=d51130e2503 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3017743">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d51130e2512 class=n-a></a>Kulikov AV, Maksyutova AV, Ivanova EA, <i> et al.</i>: The effect of thyroidectomy on the expression of the mRNA of 5-HT<sub>2A</sub> serotonin receptors in the rat frontal cortex. <i>Dokl Biochem Biophys.</i> 2002; <b>383</b>(1–6): 116–8. <a target=xrefwindow id=d51130e2526 href="http://www.ncbi.nlm.nih.gov/pubmed/12058363">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2530 href="http://dx.doi.org/10.1023/A:1015387818916">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d51130e2540 class=n-a></a>Kulikov AV, Zubkov EA: Chronic thyroxine treatment activates the 5-HT<sub>2A</sub> serotonin receptor in the mouse brain. <i>Neurosci Lett.</i> 2007; <b>416</b>(3): 307–9. <a target=xrefwindow id=d51130e2551 href="http://www.ncbi.nlm.nih.gov/pubmed/17316999">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2554 href="http://dx.doi.org/10.1016/j.neulet.2007.02.018">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d51130e2563 class=n-a></a>Cihan A, Murat N, Demir O, <i> et al.</i>: An experimental approach to the interrelationship between hyperthyroidism and ejaculation latency time in male rats. <i>J Urol.</i> 2009; <b>181</b>(2): 907–12. <a target=xrefwindow id=d51130e2574 href="http://www.ncbi.nlm.nih.gov/pubmed/19095256">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2577 href="http://dx.doi.org/10.1016/j.juro.2008.10.061">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d51130e2586 class=n-a></a>Carani C, Isidori AM, Granata A, <i> et al.</i>: Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. <i>J Clin Endocrinol Metab.</i> 2005; <b>90</b>(12): 6472–9. <a target=xrefwindow id=d51130e2597 href="http://www.ncbi.nlm.nih.gov/pubmed/16204360">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2600 href="http://dx.doi.org/10.1210/jc.2005-1135">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d51130e2609 class=n-a></a>Corona G, Jannini EA, Vignozzi L, <i> et al.</i>: The hormonal control of ejaculation. <i>Nat Rev Urol.</i> 2012; <b>9</b>(9): 508–19. <a target=xrefwindow id=d51130e2620 href="http://www.ncbi.nlm.nih.gov/pubmed/22869001">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2623 href="http://dx.doi.org/10.1038/nrurol.2012.147">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d51130e2632 class=n-a></a>Waldinger MD, Zwinderman AH, Olivier B, <i> et al.</i>: Thyroid-stimulating hormone assessments in a Dutch cohort of 620 men with lifelong premature ejaculation without erectile dysfunction. <i>J Sex Med.</i> 2005; <b>2</b>(6): 865–70. <a target=xrefwindow id=d51130e2643 href="http://www.ncbi.nlm.nih.gov/pubmed/16422811">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2646 href="http://dx.doi.org/10.1111/j.1743-6109.2005.00142.x">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d51130e2655 class=n-a></a>Screponi E, Carosa E, Di Stasi SM, <i> et al.</i>: Prevalence of chronic prostatitis in men with premature ejaculation. <i>Urology.</i> 2001; <b>58</b>(2): 198–202. <a target=xrefwindow id=d51130e2666 href="http://www.ncbi.nlm.nih.gov/pubmed/11489699">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2669 href="http://dx.doi.org/10.1016/S0090-4295(01)01151-7">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d51130e2679 class=n-a></a>El-Nashaar A, Shamloul R: Antibiotic treatment can delay ejaculation in patients with premature ejaculation and chronic bacterial prostatitis. <i>J Sex Med.</i> 2007; <b>4</b>(2): 491–6. <a target=xrefwindow id=d51130e2687 href="http://www.ncbi.nlm.nih.gov/pubmed/17367444">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2690 href="http://dx.doi.org/10.1111/j.1743-6109.2006.00243.x">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d51130e2699 class=n-a></a>Zohdy W: Clinical parameters that predict successful outcome in men with premature ejaculation and inflammatory prostatitis. <i>J Sex Med.</i> 2009; <b>6</b>(11): 3139–46. <a target=xrefwindow id=d51130e2707 href="http://www.ncbi.nlm.nih.gov/pubmed/19751386">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2710 href="http://dx.doi.org/10.1111/j.1743-6109.2009.01487.x">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d51130e2719 class=n-a></a>Shamloul R, el-Nashaar A: Chronic prostatitis in premature ejaculation: a cohort study in 153 men. <i>J Sex Med.</i> 2006; <b>3</b>(1): 150–4. <a target=xrefwindow id=d51130e2727 href="http://www.ncbi.nlm.nih.gov/pubmed/16409229">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2730 href="http://dx.doi.org/10.1111/j.1743-6109.2005.00107.x">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d51130e2739 class=n-a></a>Segraves RT: Considerations for an evidence-based definition of premature ejaculation in the DSM-V. <i>J Sex Med.</i> 2010; <b>7</b>(2 Pt 1): 672–9. <a target=xrefwindow id=d51130e2747 href="http://www.ncbi.nlm.nih.gov/pubmed/20492416">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2750 href="http://dx.doi.org/10.1111/j.1743-6109.2009.01682.x">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d51130e2759 class=n-a></a>McCabe MP, Sharlip ID, Lewis R, <i> et al.</i>: Incidence and Prevalence of Sexual Dysfunction in Women and Men: A Consensus Statement from the Fourth International Consultation on Sexual Medicine 2015. <i>J Sex Med.</i> 2016; <b>13</b>(2): 144–52. <a target=xrefwindow id=d51130e2770 href="http://www.ncbi.nlm.nih.gov/pubmed/26953829">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2773 href="http://dx.doi.org/10.1016/j.jsxm.2015.12.034">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d51130e2782 class=n-a></a>Diagnostic and Statistical Manual of Mental Disorders. 3rd (DSM III) edition. Washington: American Psychiatric Association, 1980. <a target=xrefwindow id=d51130e2784 href="http://displus.sk/DSM/subory/dsm3.pdf">Reference Source</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d51130e2794 class=n-a></a>American Psychiatric Association: Diagnostic and statistical manual of mental disorders, DSM-IV-TR, 4th edn. Washington, DC: APA, 2000. <a target=xrefwindow id=d51130e2796 href="https://justines2010blog.files.wordpress.com/2011/03/dsm-iv.pdf">Reference Source</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d51130e2805 class=n-a></a>Patrick DL, Althof SE, Pryor JL, <i> et al.</i>: Premature ejaculation: an observational study of men and their partners. <i>J Sex Med.</i> 2005; <b>2</b>(3): 358–67. <a target=xrefwindow id=d51130e2816 href="http://www.ncbi.nlm.nih.gov/pubmed/16422867">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2819 href="http://dx.doi.org/10.1111/j.1743-6109.2005.20353.x">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/14764"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d51130e2828 class=n-a></a>Waldinger MD, Schweitzer DH: Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part II--proposals for DSM-V and ICD-11. <i>J Sex Med.</i> 2006; <b>3</b>(4): 693–705. <a target=xrefwindow id=d51130e2836 href="http://www.ncbi.nlm.nih.gov/pubmed/16839326">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2839 href="http://dx.doi.org/10.1111/j.1743-6109.2006.00276.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/14764">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d51130e2852 class=n-a></a>Giuliano F, Patrick DL, Porst H, <i> et al.</i>: Premature ejaculation: results from a five-country European observational study. <i>Eur Urol.</i> 2008; <b>53</b>(5): 1048–57. <a target=xrefwindow id=d51130e2863 href="http://www.ncbi.nlm.nih.gov/pubmed/17950985">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2866 href="http://dx.doi.org/10.1016/j.eururo.2007.10.015">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d51130e2875 class=n-a></a>Waldinger MD, Schweitzer DH: Re: François Giuliano, Donald L. Patrick, Hartmut Porst, et Al. for the 3004 study group. Premature ejaculation: results from a five-country European observational study. Eur urol 2008;53:1048-57. <i>Eur Urol.</i> 2008; <b>53</b>(6): 1304–5; author reply 1305–6. <a target=xrefwindow id=d51130e2883 href="http://www.ncbi.nlm.nih.gov/pubmed/18262333">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2886 href="http://dx.doi.org/10.1016/j.eururo.2008.01.050">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d51130e2895 class=n-a></a>Laumann E, Gagnon J, Mitchael R, <i> et al.</i>: The social organization of sexuality. Sexual practices in the United States. Chicago, IL: University of Chicago Press; 1994. <a target=xrefwindow id=d51130e2900 href="https://www.abebooks.com/servlet/BookDetailsPL?bi=15628758840&amp;searchurl=tn%3Dsocial%2Borganization%2Bsexuality%2Bsexual%2Bpractices%26sortby%3D17%26an%3Dlaumann%2Bedward%2Bgagnon%2Bjohn%2Bmichael&amp;cm_sp=snippet-_-srp1-_-title25">Reference Source</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1116374"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d51130e2910 class=n-a></a>Waldinger MD: Premature ejaculation: different pathophysiologies and etiologies determine its treatment. <i>J Sex Marital Ther.</i> 2008; <b>34</b>(1): 1–13. <a target=xrefwindow id=d51130e2918 href="http://www.ncbi.nlm.nih.gov/pubmed/18396725">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2921 href="http://dx.doi.org/10.1080/00926230701640355">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1116374">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d51130e2934 class=n-a></a>Serefoglu EC, McMahon CG, Waldinger MD, <i> et al.</i>: An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. <i>J Sex Med.</i> 2014; <b>11</b>(6): 1423–41. <a target=xrefwindow id=d51130e2945 href="http://www.ncbi.nlm.nih.gov/pubmed/24848805">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2948 href="http://dx.doi.org/10.1111/jsm.12524">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d51130e2957 class=n-a></a>McCabe MP, Sharlip ID, Atalla E, <i> et al.</i>: Definitions of Sexual Dysfunctions in Women and Men: A Consensus Statement From the Fourth International Consultation on Sexual Medicine 2015. <i>J Sex Med.</i> 2016; <b>13</b>(2): 135–43. <a target=xrefwindow id=d51130e2968 href="http://www.ncbi.nlm.nih.gov/pubmed/26953828">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2971 href="http://dx.doi.org/10.1016/j.jsxm.2015.12.019">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d51130e2980 class=n-a></a>Waldinger MD, Hengeveld MW, Zwinderman AH: Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. <i>Am J Psychiatry.</i> 1994; <b>151</b>(9): 1377–9. <a target=xrefwindow id=d51130e2988 href="http://www.ncbi.nlm.nih.gov/pubmed/8067497">PubMed Abstract </a> | <a target=xrefwindow id=d51130e2991 href="http://dx.doi.org/10.1176/ajp.151.9.1377">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d51130e3000 class=n-a></a>Pryor J, Broedrick G, Ho K, <i> et al.</i>: Comparison of estimated versus measured intravaginal latency time (IELT) in men with and without premature ejaculation. <i>J Sex Med.</i> 2006; <b>3</b>(1 suppl): 53 (abstract 125). <a target=xrefwindow id=d51130e3011 href="https://insights.ovid.com/sexual-medicine/jsmed/2006/01/001/comparison-estimated-versus-measured-intravaginal/129/01222926">Reference Source</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d51130e3020 class=n-a></a>Waldinger MD, Hengeveld MW, Zwinderman AH, <i> et al.</i>: An empirical operationalization study of DSM-IV diagnostic criteria for premature ejaculation. <i>Int J Psychiatry Clin Pract.</i> 1998; <b>2</b>(4): 287–93. <a target=xrefwindow id=d51130e3031 href="http://www.ncbi.nlm.nih.gov/pubmed/24927094">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3034 href="http://dx.doi.org/10.3109/13651509809115376">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d51130e3044 class=n-a></a>Waldinger MD, Zwinderman AH, Olivier B, <i> et al.</i>: Proposal for a definition of lifelong premature ejaculation based on epidemiological stopwatch data. <i>J Sex Med.</i> 2005; <b>2</b>(4): 498–507. <a target=xrefwindow id=d51130e3055 href="http://www.ncbi.nlm.nih.gov/pubmed/16422844">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3058 href="http://dx.doi.org/10.1111/j.1743-6109.2005.00069.x">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d51130e3067 class=n-a></a>McMahon CG: Long term results of treatment of premature ejaculation with selective serotonin re-uptake inhibitors. <i>Int J Impot Res.</i> 2002; <b>14</b>(3suppl): S19. <a target=xrefwindow id=d51130e3075 href="https://www.researchgate.net/publication/301347136_Long_term_results_of_treatment_of_premature_ejaculation_with_selective_serotonin_re-uptake_inhibitors">Reference Source</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d51130e3084 class=n-a></a>Waldinger MD, Zwinderman AH, Olivier B, <i> et al.</i>: The majority of men with lifelong premature ejaculation prefer daily drug treatment: an observation study in a consecutive group of Dutch men. <i>J Sex Med.</i> 2007; <b>4</b>(4 Pt 1): 1028–37. <a target=xrefwindow id=d51130e3095 href="http://www.ncbi.nlm.nih.gov/pubmed/17627747">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3098 href="http://dx.doi.org/10.1111/j.1743-6109.2007.00528.x">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d51130e3107 class=n-a></a>Hatzimouratidis K, Giuliano F, Moncada I, <i> et al.</i>: EAU guidelines on erectile dysfunction, premature ejaculation, penile curvarture and priapism. <a target=xrefwindow id=d51130e3112 href="https://uroweb.org/wp-content/uploads/EAU-Guidelines-Male-Sexual-Dysfunction-2016-3.pdf">Reference Source</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d51130e3121 class=n-a></a>Montague D, Jarrow J, Broderick G, <i> et al.</i>: Pharmacologic management of premature ejaculation. <a target=xrefwindow id=d51130e3126 href="http://www.auanet.org/guidelines/premature-ejaculation-(2004-reviewed-and-validity-confirmed-2010)">Reference Source</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d51130e3135 class=n-a></a>Althof S, Rosen R, Symonds T, <i> et al.</i>: Development and validation of a new questionnaire to assess sexual satisfaction, control, and distress associated with premature ejaculation. <i>J Sex Med.</i> 2006; <b>3</b>(3): 465–75. <a target=xrefwindow id=d51130e3146 href="http://www.ncbi.nlm.nih.gov/pubmed/16681472">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3149 href="http://dx.doi.org/10.1111/j.1743-6109.2006.00239.x">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d51130e3159 class=n-a></a>Patrick DL, Giuliano F, Ho KF, <i> et al.</i>: The Premature Ejaculation Profile: validation of self-reported outcome measures for research and practice. <i>BJU Int.</i> 2009; <b>103</b>(3): 358–64. <a target=xrefwindow id=d51130e3170 href="http://www.ncbi.nlm.nih.gov/pubmed/18793300">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3173 href="http://dx.doi.org/10.1111/j.1464-410X.2008.08041.x">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d51130e3182 class=n-a></a>Symonds T, Perelman MA, Althof S, <i> et al.</i>: Development and validation of a premature ejaculation diagnostic tool. <i>Eur Urol.</i> 2007; <b>52</b>(2): 565–73. <a target=xrefwindow id=d51130e3193 href="http://www.ncbi.nlm.nih.gov/pubmed/17275165">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3196 href="http://dx.doi.org/10.1016/j.eururo.2007.01.028">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d51130e3205 class=n-a></a>Yuan YM, Xin ZC, Jiang H, <i> et al.</i>: Sexual function of premature ejaculation patients assayed with Chinese Index of Premature Ejaculation. <i>Asian J Androl.</i> 2004; <b>6</b>(2): 121–6. <a target=xrefwindow id=d51130e3216 href="http://www.ncbi.nlm.nih.gov/pubmed/15154086">PubMed Abstract </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726766593"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d51130e3225 class=n-a></a>Althof SE: Patient reported outcomes in the assessment of premature ejaculation. <i>Transl Androl Urol.</i> 2016; <b>5</b>(4): 470–4. <a target=xrefwindow id=d51130e3233 href="http://www.ncbi.nlm.nih.gov/pubmed/27652219">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3236 href="http://dx.doi.org/10.21037/tau.2016.05.04">Publisher Full Text </a> | <a target=xrefwindow id=d51130e3239 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5001997">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726766593">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d51130e3252 class=n-a></a>McMahon CG: The design and methodology of premature ejaculation interventional studies. <i>Transl Androl Urol.</i> 2016; <b>5</b>(4): 508–25. <a target=xrefwindow id=d51130e3260 href="http://www.ncbi.nlm.nih.gov/pubmed/27652224">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3263 href="http://dx.doi.org/10.21037/tau.2016.03.28">Publisher Full Text </a> | <a target=xrefwindow id=d51130e3266 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5002005">Free Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d51130e3275 class=n-a></a>Rosen RC, Riley A, Wagner G, <i> et al.</i>: The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. <i>Urology.</i> 1997; <b>49</b>(6): 822–30. <a target=xrefwindow id=d51130e3286 href="http://www.ncbi.nlm.nih.gov/pubmed/9187685">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3289 href="http://dx.doi.org/10.1016/S0090-4295(97)00238-0">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d51130e3299 class=n-a></a>Cayan S, Serefoğlu EC: Advances in treating premature ejaculation. <i>F1000Prime Rep.</i> 2014; <b>6</b>: 55. <a target=xrefwindow id=d51130e3307 href="http://www.ncbi.nlm.nih.gov/pubmed/25184045">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3310 href="http://dx.doi.org/10.12703/P6-55">Publisher Full Text </a> | <a target=xrefwindow id=d51130e3313 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4108949">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726066314"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d51130e3322 class=n-a></a>Castiglione F, Albersen M, Hedlund P, <i> et al.</i>: Current Pharmacological Management of Premature Ejaculation: A Systematic Review and Meta-analysis. <i>Eur Urol.</i> 2016; <b>69</b>(5): 904–16. <a target=xrefwindow id=d51130e3333 href="http://www.ncbi.nlm.nih.gov/pubmed/26749092">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3336 href="http://dx.doi.org/10.1016/j.eururo.2015.12.028">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726066314">F1000 Recommendation</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725875495"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d51130e3349 class=n-a></a>Cooper K, Martyn-St James M, Kaltenthaler E, <i> et al.</i>: Behavioral Therapies for Management of Premature Ejaculation: A Systematic Review. <i>Sex Med.</i> 2015; <b>3</b>(3): 174–88. <a target=xrefwindow id=d51130e3360 href="http://www.ncbi.nlm.nih.gov/pubmed/26468381">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3363 href="http://dx.doi.org/10.1002/sm2.65">Publisher Full Text </a> | <a target=xrefwindow id=d51130e3367 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4599555">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725875495">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725563406"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d51130e3380 class=n-a></a>Cormio L, Massenio P, La Rocca R, <i> et al.</i>: The Combination of Dapoxetine and Behavioral Treatment Provides Better Results than Dapoxetine Alone in the Management of Patients with Lifelong Premature Ejaculation. <i>J Sex Med.</i> 2015; <b>12</b>(7): 1609–15. <a target=xrefwindow id=d51130e3391 href="http://www.ncbi.nlm.nih.gov/pubmed/26077706">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3394 href="http://dx.doi.org/10.1111/jsm.12925">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725563406">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/5356957"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d51130e3407 class=n-a></a>Carson C, Wyllie M: Improved ejaculatory latency, control and sexual satisfaction when PSD502 is applied topically in men with premature ejaculation: results of a phase III, double-blind, placebo-controlled study. <i>J Sex Med.</i> 2010; <b>7</b>(9): 3179–89. <a target=xrefwindow id=d51130e3415 href="http://www.ncbi.nlm.nih.gov/pubmed/20584124">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3418 href="http://dx.doi.org/10.1111/j.1743-6109.2010.01913.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/5356957">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d51130e3431 class=n-a></a>McMahon CG: Emerging and investigational drugs for premature ejaculation. <i>Transl Androl Urol.</i> 2016; <b>5</b>(4): 487–501. <a target=xrefwindow id=d51130e3439 href="http://www.ncbi.nlm.nih.gov/pubmed/27652222">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3442 href="http://dx.doi.org/10.21037/tau.2016.04.02">Publisher Full Text </a> | <a target=xrefwindow id=d51130e3445 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5001989">Free Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d51130e3455 class=n-a></a>Dinsmore WW, Wyllie MG: PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study. <i>BJU Int.</i> 2009; <b>103</b>(7): 940–9. <a target=xrefwindow id=d51130e3463 href="http://www.ncbi.nlm.nih.gov/pubmed/19245438">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3466 href="http://dx.doi.org/10.1111/j.1464-410X.2009.08456.x">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d51130e3475 class=n-a></a>McMahon CG, Touma K: Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies. <i>J Urol.</i> 1999; <b>161</b>(6): 1826–30. <a target=xrefwindow id=d51130e3483 href="http://www.ncbi.nlm.nih.gov/pubmed/10332446">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3486 href="http://dx.doi.org/10.1016/S0022-5347(05)68816-7">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d51130e3495 class=n-a></a>Strassberg DS, de Gouveia Brazao CA, Rowland DL, <i> et al.</i>: Clomipramine in the treatment of rapid (premature) ejaculation. <i>J Sex Marital Ther.</i> 1999; <b>25</b>(2): 89–101. <a target=xrefwindow id=d51130e3506 href="http://www.ncbi.nlm.nih.gov/pubmed/10327378">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3509 href="http://dx.doi.org/10.1080/00926239908403982">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d51130e3518 class=n-a></a>Kim SW, Paick JS: Short-term analysis of the effects of as needed use of sertraline at 5 PM for the treatment of premature ejaculation. <i>Urology.</i> 1999; <b>54</b>(3): 544–7. <a target=xrefwindow id=d51130e3526 href="http://www.ncbi.nlm.nih.gov/pubmed/10475369">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3529 href="http://dx.doi.org/10.1016/S0090-4295(99)00187-9">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d51130e3538 class=n-a></a>Waldinger MD, Zwinderman AH, Olivier B: On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment. <i>Eur Urol.</i> 2004; <b>46</b>(4): 510–5; discussion 516. <a target=xrefwindow id=d51130e3546 href="http://www.ncbi.nlm.nih.gov/pubmed/15363569">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3549 href="http://dx.doi.org/10.1016/j.eururo.2004.05.005">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1009800"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d51130e3558 class=n-a></a>Truitt WA, Coolen LM: Identification of a potential ejaculation generator in the spinal cord. <i>Science.</i> 2002; <b>297</b>(5586): 1566–9. <a target=xrefwindow id=d51130e3566 href="http://www.ncbi.nlm.nih.gov/pubmed/12202834">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3569 href="http://dx.doi.org/10.1126/science.1073885">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1009800">F1000 Recommendation</a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718095628"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d51130e3583 class=n-a></a>Mirone V, Arcaniolo D, Rivas D, <i> et al.</i>: Results from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study. <i>Eur Urol.</i> 2014; <b>65</b>(4): 733–9. <a target=xrefwindow id=d51130e3594 href="http://www.ncbi.nlm.nih.gov/pubmed/23993257">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3597 href="http://dx.doi.org/10.1016/j.eururo.2013.08.018">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718095628">F1000 Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727505180"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d51130e3610 class=n-a></a>Park HJ, Park NC, Kim TN, <i> et al.</i>: Discontinuation of Dapoxetine Treatment in Patients With Premature Ejaculation: A 2-Year Prospective Observational Study. <i>Sex Med.</i> 2017; <b>5</b>(2): e99–e105. <a target=xrefwindow id=d51130e3621 href="http://www.ncbi.nlm.nih.gov/pubmed/28395997">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3624 href="http://dx.doi.org/10.1016/j.esxm.2017.02.003">Publisher Full Text </a> | <a target=xrefwindow id=d51130e3628 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5440632">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727505180">F1000 Recommendation</a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d51130e3641 class=n-a></a>Mancina R, Filippi S, Marini M, <i> et al.</i>: Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens. <i>Mol Hum Reprod.</i> 2005; <b>11</b>(2): 107–15. <a target=xrefwindow id=d51130e3652 href="http://www.ncbi.nlm.nih.gov/pubmed/15640438">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3655 href="http://dx.doi.org/10.1093/molehr/gah143">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d51130e3664 class=n-a></a>Uckert S, Oelke M, Stief CG, <i> et al.</i>: Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate. <i>Eur Urol.</i> 2006; <b>49</b>(4): 740–5. <a target=xrefwindow id=d51130e3675 href="http://www.ncbi.nlm.nih.gov/pubmed/16460876">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3678 href="http://dx.doi.org/10.1016/j.eururo.2005.12.050">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d51130e3687 class=n-a></a>Mamas MA, Reynard JM, Brading AF: Nitric oxide and the lower urinary tract: current concepts, future prospects. <i>Urology.</i> 2003; <b>61</b>(6): 1079–85. <a target=xrefwindow id=d51130e3695 href="http://www.ncbi.nlm.nih.gov/pubmed/12809865">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3698 href="http://dx.doi.org/10.1016/S0090-4295(03)00131-6">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d51130e3707 class=n-a></a>Laumann EO, Nicolosi A, Glasser DB, <i> et al.</i>: Sexual problems among women and men aged 40–80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. <i>Int J Impot Res.</i> 2005; <b>17</b>(1): 39–57. <a target=xrefwindow id=d51130e3718 href="http://www.ncbi.nlm.nih.gov/pubmed/15215881">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3721 href="http://dx.doi.org/10.1038/sj.ijir.3901250">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d51130e3731 class=n-a></a>Porst H, Montorsi F, Rosen RC, <i> et al.</i>: The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. <i>Eur Urol.</i> 2007; <b>51</b>(3): 816–23; discussion 824. <a target=xrefwindow id=d51130e3742 href="http://www.ncbi.nlm.nih.gov/pubmed/16934919">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3745 href="http://dx.doi.org/10.1016/j.eururo.2006.07.004">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d51130e3754 class=n-a></a>Basile Fasolo C, Mirone V, Gentile V, <i> et al.</i>: Premature ejaculation: prevalence and associated conditions in a sample of 12,558 men attending the andrology prevention week 2001--a study of the Italian Society of Andrology (SIA). <i>J Sex Med.</i> 2005; <b>2</b>(3): 376–82. <a target=xrefwindow id=d51130e3765 href="http://www.ncbi.nlm.nih.gov/pubmed/16422869">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3768 href="http://dx.doi.org/10.1111/j.1743-6109.2005.20350.x">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d51130e3777 class=n-a></a>Jannini EA, Lombardo F, Lenzi A: Correlation between ejaculatory and erectile dysfunction. <i>Int J Androl.</i> 2005; <b>28 Suppl 2</b>: 40–5. <a target=xrefwindow id=d51130e3785 href="http://www.ncbi.nlm.nih.gov/pubmed/16236063">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3788 href="http://dx.doi.org/10.1111/j.1365-2605.2005.00593.x">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d51130e3797 class=n-a></a>McMahon CG: Screening for erectile dysfunction in men with lifelong premature ejaculation--Is the Sexual Health Inventory for Men (SHIM) reliable? <i>J Sex Med.</i> 2009; <b>6</b>(2): 567–73. <a target=xrefwindow id=d51130e3805 href="http://www.ncbi.nlm.nih.gov/pubmed/19215618">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3808 href="http://dx.doi.org/10.1111/j.1743-6109.2008.01092.x">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718446927"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d51130e3817 class=n-a></a>McMahon CG, McMahon CN, Leow LJ, <i> et al.</i>: Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: a systematic review. <i>BJU Int.</i> 2006; <b>98</b>(2): 259–72. <a target=xrefwindow id=d51130e3828 href="http://www.ncbi.nlm.nih.gov/pubmed/16879663">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3831 href="http://dx.doi.org/10.1111/j.1464-410X.2006.06290.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718446927">F1000 Recommendation</a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d51130e3844 class=n-a></a>Gameel TA, Tawfik AM, Abou-Farha MO, <i> et al.</i>: On-demand use of tramadol, sildenafil, paroxetine and local anaesthetics for the management of premature ejaculation: A randomised placebo-controlled clinical trial. <i>Arab J Urol.</i> 2013; <b>11</b>(4): 392–7. <a target=xrefwindow id=d51130e3855 href="http://www.ncbi.nlm.nih.gov/pubmed/26558110">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3858 href="http://dx.doi.org/10.1016/j.aju.2013.05.003">Publisher Full Text </a> | <a target=xrefwindow id=d51130e3862 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4443019">Free Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1165753"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d51130e3872 class=n-a></a>Aversa A, Pili M, Francomano D, <i> et al.</i>: Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation. <i>Int J Impot Res.</i> 2009; <b>21</b>(4): 221–7. <a target=xrefwindow id=d51130e3883 href="http://www.ncbi.nlm.nih.gov/pubmed/19474796">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3886 href="http://dx.doi.org/10.1038/ijir.2009.21">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1165753">F1000 Recommendation</a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d51130e3899 class=n-a></a>Mattos RM, Marmo Lucon A, Srougi M: Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study. <i>Urol Int.</i> 2008; <b>80</b>(2): 162–5. <a target=xrefwindow id=d51130e3907 href="http://www.ncbi.nlm.nih.gov/pubmed/18362486">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3910 href="http://dx.doi.org/10.1159/000112607">Publisher Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d51130e3919 class=n-a></a>Jeon HJ, Kim HS, Lee CH, <i> et al.</i>: Candidate molecule for premature ejaculation, DA-8031: <i>in vivo</i> and <i>in vitro</i> characterization of DA-8031. <i>Urology.</i> 2011; <b>77</b>(4): 1006.e17–21. <a target=xrefwindow id=d51130e3937 href="http://www.ncbi.nlm.nih.gov/pubmed/21256578">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3940 href="http://dx.doi.org/10.1016/j.urology.2010.11.046">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d51130e3949 class=n-a></a>Kang KK, Ahn GJ, Sung JH, <i> et al.</i>: Ejaculatory responses are inhibited by a new chemical entity, DA-8031, in preclinical rodent models of ejaculation. <i>Urology.</i> 2013; <b>81</b>(4): 920.e13–8. <a target=xrefwindow id=d51130e3960 href="http://www.ncbi.nlm.nih.gov/pubmed/23394880">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3963 href="http://dx.doi.org/10.1016/j.urology.2012.12.006">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732149557"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d51130e3972 class=n-a></a>Shin D, Lee S, Yi S, <i> et al.</i>: Pharmacokinetics and tolerability of DA-8031, a novel selective serotonin reuptake inhibitor for premature ejaculation in healthy male subjects. <i>Drug Des Devel Ther.</i> 2017; <b>11</b>: 713–23. <a target=xrefwindow id=d51130e3983 href="http://www.ncbi.nlm.nih.gov/pubmed/28331291">PubMed Abstract </a> | <a target=xrefwindow id=d51130e3986 href="http://dx.doi.org/10.2147/DDDT.S126861">Publisher Full Text </a> | <a target=xrefwindow id=d51130e3990 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5354528">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732149557">F1000 Recommendation</a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d51130e4003 class=n-a></a>McMahon CG: Current and Emerging Treatments for Premature Ejaculation. <i>Sex Med Rev.</i> 2015; <b>3</b>(3): 183–202. <a target=xrefwindow id=d51130e4011 href="http://www.ncbi.nlm.nih.gov/pubmed/27784609">PubMed Abstract </a> | <a target=xrefwindow id=d51130e4014 href="http://dx.doi.org/10.1002/smrj.49">Publisher Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d51130e4024 class=n-a></a>Ivell R, Balvers M, Rust W, <i> et al.</i>: Oxytocin and male reproductive function. <i>Adv Exp Med Biol.</i> 1997; <b>424</b>: 253–64. <a target=xrefwindow id=d51130e4035 href="http://www.ncbi.nlm.nih.gov/pubmed/9361803">PubMed Abstract </a> | <a target=xrefwindow id=d51130e4038 href="http://dx.doi.org/10.1007/978-1-4615-5913-9_47">Publisher Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d51130e4047 class=n-a></a>Cantor JM, Binik YM, Pfaus JG: Chronic fluoxetine inhibits sexual behavior in the male rat: reversal with oxytocin. <i>Psychopharmacology (Berl).</i> 1999; <b>144</b>(4): 355–62. <a target=xrefwindow id=d51130e4055 href="http://www.ncbi.nlm.nih.gov/pubmed/10435408">PubMed Abstract </a> | <a target=xrefwindow id=d51130e4058 href="http://dx.doi.org/10.1007/s002130051018">Publisher Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d51130e4067 class=n-a></a>Argiolas A, Collu M, D'Aquila P, <i> et al.</i>: Apomorphine stimulation of male copulatory behavior is prevented by the oxytocin antagonist d(CH<sub>2</sub>)<sub>5</sub> Tyr(Me)-Orn<sup>8</sup>-vasotocin in rats. <i>Pharmacol Biochem Behav.</i> 1989; <b>33</b>(1): 81–3. <a target=xrefwindow id=d51130e4088 href="http://www.ncbi.nlm.nih.gov/pubmed/2780793">PubMed Abstract </a> | <a target=xrefwindow id=d51130e4091 href="http://dx.doi.org/10.1016/0091-3057(89)90433-4">Publisher Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718100517"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d51130e4100 class=n-a></a>Clément P, Bernabé J, Compagnie S, <i> et al.</i>: Inhibition of ejaculation by the non-peptide oxytocin receptor antagonist GSK557296: a multi-level site of action. <i>Br J Pharmacol.</i> 2013; <b>169</b>(7): 1477–85. <a target=xrefwindow id=d51130e4111 href="http://www.ncbi.nlm.nih.gov/pubmed/23530818">PubMed Abstract </a> | <a target=xrefwindow id=d51130e4114 href="http://dx.doi.org/10.1111/bph.12198">Publisher Full Text </a> | <a target=xrefwindow id=d51130e4118 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3724105">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718100517">F1000 Recommendation</a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d51130e4131 class=n-a></a>Clement PBJ, Compagnie S, McCallum S, <i> et al.</i>: Effect of selective oxytocin receptor antagonist GSK557296 on pharmacologically-induced ejaculation in anaesthetised rat ejaculation. <i>Proceedings of the world meeting on sexual medicine</i>,Chicago, USA <i>J Sex Med.</i> 2012; <b>9</b>: 183–298 (abstract#137). </span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d51130e4152 class=n-a></a>McMahon C, Osterloh I, Rosen R, <i> et al.</i>: A phase IIA study to investigate the efficacy and safety of the selective oxytocin receptor antagonist, IX-01, in men with lifelong Premature ejaculation. <i>JU.</i> 2017; <b>197</b>(4S): e1344. <a target=xrefwindow id=d51130e4163 href="http://dx.doi.org/10.1016/j.juro.2017.02.3142">Publisher Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d51130e4173 class=n-a></a>Ballon JS, Feifel D: A systematic review of modafinil: Potential clinical uses and mechanisms of action. <i>J Clin Psychiatry.</i> 2006; <b>67</b>(4): 554–66. <a target=xrefwindow id=d51130e4181 href="http://www.ncbi.nlm.nih.gov/pubmed/16669720">PubMed Abstract </a> | <a target=xrefwindow id=d51130e4184 href="http://dx.doi.org/10.4088/JCP.v67n0406">Publisher Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d51130e4193 class=n-a></a>Marson L, Yu G, Farber NM: The effects of oral administration of d-modafinil on male rat ejaculatory behavior. <i>J Sex Med.</i> 2010; <b>7</b>(1 Pt 1): 70–8. <a target=xrefwindow id=d51130e4201 href="http://www.ncbi.nlm.nih.gov/pubmed/19796055">PubMed Abstract </a> | <a target=xrefwindow id=d51130e4204 href="http://dx.doi.org/10.1111/j.1743-6109.2009.01509.x">Publisher Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d51130e4213 class=n-a></a>Qu WM, Huang ZL, Xu XH, <i> et al.</i>: Dopaminergic D<sub>1</sub> and D<sub>2</sub> receptors are essential for the arousal effect of modafinil. <i>J Neurosci.</i> 2008; <b>28</b>(34): 8462–9. <a target=xrefwindow id=d51130e4231 href="http://www.ncbi.nlm.nih.gov/pubmed/18716204">PubMed Abstract </a> | <a target=xrefwindow id=d51130e4234 href="http://dx.doi.org/10.1523/JNEUROSCI.1819-08.2008">Publisher Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d51130e4243 class=n-a></a>Korotkova TM, Klyuch BP, Ponomarenko AA, <i> et al.</i>: Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors. <i>Neuropharmacology.</i> 2007; <b>52</b>(2): 626–33. <a target=xrefwindow id=d51130e4254 href="http://www.ncbi.nlm.nih.gov/pubmed/17070873">PubMed Abstract </a> | <a target=xrefwindow id=d51130e4257 href="http://dx.doi.org/10.1016/j.neuropharm.2006.09.005">Publisher Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d51130e4266 class=n-a></a>Ferraro L, Fuxe K, Tanganelli S, <i> et al.</i>: Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rat by modafinil: possible relevance for wakefulness and depression. <i>J Neurosci Res.</i> 2002; <b>68</b>(1): 107–12. <a target=xrefwindow id=d51130e4277 href="http://www.ncbi.nlm.nih.gov/pubmed/11933055">PubMed Abstract </a> | <a target=xrefwindow id=d51130e4280 href="http://dx.doi.org/10.1002/jnr.10196">Publisher Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d51130e4289 class=n-a></a>Schapiro B: Premature Ejaculation: A Review of 1130 Cases. <i>J Urol.</i> 1943; <b>50</b>(3): 374–9. <a target=xrefwindow id=d51130e4297 href="http://dx.doi.org/10.1016/S0022-5347(17)70462-4">Publisher Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d51130e4307 class=n-a></a>Waldinger MD, Berendsen HH, Blok BF, <i> et al.</i>: Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system. <i>Behav Brain Res.</i> 1998; <b>92</b>(2): 111–8. <a target=xrefwindow id=d51130e4318 href="http://www.ncbi.nlm.nih.gov/pubmed/9638953">PubMed Abstract </a> | <a target=xrefwindow id=d51130e4321 href="http://dx.doi.org/10.1016/S0166-4328(97)00183-6">Publisher Full Text </a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d51130e4330 class=n-a></a>Park HS, Jung IS, Lim NH, <i> et al.</i>: Proof of mechanism study of a novel serotonin transporter blocker, DA-8031, using [<sup>11</sup>C]DASB positron emission tomography and <i>in vivo</i> microdialysis. <i>Urology.</i> 2014; <b>84</b>(1): 245.e1–7. <a target=xrefwindow id=d51130e4348 href="http://www.ncbi.nlm.nih.gov/pubmed/24824409">PubMed Abstract </a> | <a target=xrefwindow id=d51130e4351 href="http://dx.doi.org/10.1016/j.urology.2014.03.014">Publisher Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726337611"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d51130e4360 class=n-a></a>Tuken M, Kiremit MC, Serefoglu EC: On-demand Modafinil Improves Ejaculation Time and Patient-reported Outcomes in Men With Lifelong Premature Ejaculation. <i>Urology.</i> 2016; <b>94</b>: 139–42. <a target=xrefwindow id=d51130e4368 href="http://www.ncbi.nlm.nih.gov/pubmed/27151339">PubMed Abstract </a> | <a target=xrefwindow id=d51130e4371 href="http://dx.doi.org/10.1016/j.urology.2016.04.036">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726337611">F1000 Recommendation</a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d51130e4384 class=n-a></a>Cavallini G: Alpha-1 blockade pharmacotherapy in primitive psychogenic premature ejaculation resistant to psychotherapy. <i>Eur Urol.</i> 1995; <b>28</b>(2): 126–30. <a target=xrefwindow id=d51130e4392 href="http://www.ncbi.nlm.nih.gov/pubmed/8529737">PubMed Abstract </a> | <a target=xrefwindow id=d51130e4395 href="http://dx.doi.org/10.1159/000475036">Publisher Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a name=d51130e4404 class=n-a></a>Başar MM, Yilmaz E, Ferhat M, <i> et al.</i>: Terazosin in the treatment of premature ejaculation: a short-term follow-up. <i>Int Urol Nephrol.</i> 2005; <b>37</b>(4): 773–7. <a target=xrefwindow id=d51130e4415 href="http://www.ncbi.nlm.nih.gov/pubmed/16362597">PubMed Abstract </a> | <a target=xrefwindow id=d51130e4418 href="http://dx.doi.org/10.1007/s11255-005-3616-4">Publisher Full Text </a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/8892957"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d51130e4427 class=n-a></a>Chapple CR, Montorsi F, Tammela TL, <i> et al.</i>: Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe. <i>Eur Urol.</i> 2011; <b>59</b>(3): 342–52. <a target=xrefwindow id=d51130e4438 href="http://www.ncbi.nlm.nih.gov/pubmed/21109344">PubMed Abstract </a> | <a target=xrefwindow id=d51130e4441 href="http://dx.doi.org/10.1016/j.eururo.2010.10.046">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/8892957">F1000 Recommendation</a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d51130e4455 class=n-a></a>Yoshida M, Kudoh J, Homma Y, <i> et al.</i>: Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia. <i>Clin Interv Aging.</i> 2011; <b>6</b>: 161–72. <a target=xrefwindow id=d51130e4466 href="http://www.ncbi.nlm.nih.gov/pubmed/21753871">PubMed Abstract </a> | <a target=xrefwindow id=d51130e4469 href="http://dx.doi.org/10.2147/CIA.S13803">Publisher Full Text </a> | <a target=xrefwindow id=d51130e4473 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3131986">Free Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a name=d51130e4482 class=n-a></a>Roehrborn CG, Kaplan SA, Lepor H, <i> et al.</i>: Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH. <i>Prostate Cancer Prostatic Dis.</i> 2011; <b>14</b>(2): 143–8. <a target=xrefwindow id=d51130e4493 href="http://www.ncbi.nlm.nih.gov/pubmed/21135869">PubMed Abstract </a> | <a target=xrefwindow id=d51130e4496 href="http://dx.doi.org/10.1038/pcan.2010.46">Publisher Full Text </a> | <a target=xrefwindow id=d51130e4500 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3094762">Free Full Text </a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a name=d51130e4509 class=n-a></a>Homma Y, Kawabe K, Takeda M, <i> et al.</i>: Ejaculation disorder is associated with increased efficacy of silodosin for benign prostatic hyperplasia. <i>Urology.</i> 2010; <b>76</b>(6): 1446–50. <a target=xrefwindow id=d51130e4520 href="http://www.ncbi.nlm.nih.gov/pubmed/20472263">PubMed Abstract </a> | <a target=xrefwindow id=d51130e4523 href="http://dx.doi.org/10.1016/j.urology.2010.03.015">Publisher Full Text </a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a name=d51130e4532 class=n-a></a>Sato Y, Tanda H, Nakajima H, <i> et al.</i>: Silodosin and its potential for treating premature ejaculation: a preliminary report. <i>Int J Urol.</i> 2012; <b>19</b>(3): 268–72. <a target=xrefwindow id=d51130e4543 href="http://www.ncbi.nlm.nih.gov/pubmed/22188258">PubMed Abstract </a> | <a target=xrefwindow id=d51130e4546 href="http://dx.doi.org/10.1111/j.1442-2042.2011.02941.x">Publisher Full Text </a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d51130e4555 class=n-a></a>Akin Y, Gulmez H, Ates M, <i> et al.</i>: Comparison of alpha blockers in treatment of premature ejaculation: a pilot clinical trial. <i>Iran Red Crescent Med J.</i> 2013; <b>15</b>(10): e13805. <a target=xrefwindow id=d51130e4566 href="http://www.ncbi.nlm.nih.gov/pubmed/24693363">PubMed Abstract </a> | <a target=xrefwindow id=d51130e4569 href="http://dx.doi.org/10.5812/ircmj.13805">Publisher Full Text </a> | <a target=xrefwindow id=d51130e4573 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3950775">Free Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a name=d51130e4582 class=n-a></a>Serefoglu EC, Hawley WR, Lasker GF, <i> et al.</i>: Effect of botulinum-A toxin injection into bulbospongiosus muscle on ejaculation latency in male rats. <i>J Sex Med.</i> 2014; <b>11</b>(7): 1657–63. <a target=xrefwindow id=d51130e4593 href="http://www.ncbi.nlm.nih.gov/pubmed/24774776">PubMed Abstract </a> | <a target=xrefwindow id=d51130e4596 href="http://dx.doi.org/10.1111/jsm.12553">Publisher Full Text </a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a name=d51130e4606 class=n-a></a>Gaxiola GM, Aguilar IE, Paz GP: Method for treating premature ejaculation with a botulinum neurotoxin. USA. 2012. <a target=xrefwindow id=d51130e4608 href="https://www.google.com/patents/US20120148563">Reference Source</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 04 Dec 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-2084.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-2084.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Andrology, University College London Medical School, London, W1G 8PH, UK<br/> <sup>2</sup> Urology Department, University of Tanta, Tanta, Egypt<br/> <p> <div class=margin-bottom> Odunayo Kalejaiye <br/> <span>Roles: </span> Writing – Original Draft Preparation </div> <div class=margin-bottom> Khaled Almekaty <br/> <span>Roles: </span> Writing – Review & Editing </div> <div class=margin-bottom> Gideon Blecher <br/> <span>Roles: </span> Writing – Review & Editing </div> <div class=margin-bottom> Suks Minhas <br/> <span>Roles: </span> Conceptualization, Supervision, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-2084/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 04 Dec 2017, 6:2084 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.12150.1">https://doi.org/10.12688/f1000research.12150.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Kalejaiye O <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=13152 data-id=12150 data-downloads="" data-views="" data-scholar="10.12688/f1000research.12150.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-2084/v1/pdf?article_uuid=aaad83d5-9adf-4666-8d6e-14d5c966dd0a" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.12150.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Kalejaiye O, Almekaty K, Blecher G and Minhas S. Premature ejaculation: challenging new and the old concepts [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2084 (<a href="https://doi.org/10.12688/f1000research.12150.1" target=_blank>https://doi.org/10.12688/f1000research.12150.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=12150 id=mobile-track-article-signin-12150 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/12150?target=/articles/6-2084.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=13152 /> <input name=articleId type=hidden value=12150 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Ege Can Serefoglu</strong>, UroKlinik Urology Center, Turkey </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Emmanuele A Jannini</strong>, School of Sexology, Department of Experimental Medicine, University of L'Aquila, Italy </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 04 Dec 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-2084.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-2084.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=28422-28388></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=28423-28389></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-2084/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>04 Dec 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Ege Can Serefoglu</strong>, UroKlinik Urology Center, Turkey </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Emmanuele A Jannini</strong>, School of Sexology, Department of Experimental Medicine, University of L'Aquila, Italy </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-2084.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-2084/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Premature ejaculation: challenging new and...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-2084/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-2084/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-2084/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Kalejaiye O et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-2084/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-2084",
            templates : {
                twitter : "Premature ejaculation: challenging new and the old concepts. Kalejaiye O et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-2084/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Premature ejaculation: challenging new and the old concepts", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Premature ejaculation: challenging new and the old concepts", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/12150/13152")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "13152");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "28388": 0,
                           "28389": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "30c6e520-25d0-4790-a60d-e4c9631460f2";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2084.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2084.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2084.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-2084.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-2084.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>